urea has been researched along with landiolol in 300 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 16 (5.33) | 18.2507 |
| 2000's | 89 (29.67) | 29.6817 |
| 2010's | 166 (55.33) | 24.3611 |
| 2020's | 29 (9.67) | 2.80 |
| Authors | Studies |
|---|---|
| Hachiya, K; Hayashi, A; Ichioka, Y; Iguchi, S; Iwamura, H; Kawamura, M; Kobayashi, K; Nishizaki, M; Sakaki, K; Senokuchi, K | 1 |
| Atsuki, K; Henmi, S; Imaizumi, K; Imaizumi, Y; Kawasumi, H; Muraki, K; Nagano, N; Nakagawa, H; Nakanishi, T; Tokuno, T; Watanabe, M | 1 |
| Inoue, T; Kitamura, A; Ogawa, R; Sakamoto, A | 1 |
| Aze, Y; Fujita, T; Kasahara, T; Nanba, T; Shinomiya, K; Yamaguchi, K; Yanagisawa, Y; Yonezawa, H | 1 |
| Fujita, T; Nishibata, K; Oida, H; Sakai, M; Shimizu, K; Shinomiya, K; Suzuki, Y; Yamaguchi, K; Yanagi, H; Yonezawa, H | 1 |
| Fujita, T; Oida, H; Shichino, Y; Shimizu, K; Suzuki, Y; Tanaka, M; Ueda, H; Yamaguchi, K; Yanagi, H; Yonezawa, H | 1 |
| Chihara, N; Fujita, T; Mori, H; Nishimura, T; Oku, H; Ozeki, Y; Shinomiya, K | 1 |
| Chihara, N; Fujita, T; Nakagawa, Y; Nishimura, T; Ozeki, Y; Sakamoto, T; Shimouchi, K; Shirakawa, R; Sugai, S; Tanaka, M | 1 |
| Aze, Y; Chihara, N; Fujita, T; Nakagawa, Y; Nishimura, T; Ozeki, Y; Sakamoto, T; Shimouchi, K; Tanaka, M | 1 |
| Aze, Y; Chihara, N; Fujita, T; Nakagawa, Y; Nishimura, T; Ozeki, Y; Sakamoto, T; Shimouchi, K; Shirakawa, R; Sugai, S | 1 |
| Hagihara, A; Hashimoto, K; Motomura, S; Narumi, Y | 1 |
| Yoshiya, I | 1 |
| Ahmet, I; Chang, JC; Fukushima, N; Kadoba, K; Kagisaki, K; Masai, T; Matsuda, H; Sawa, Y; Yamaguchi, T | 1 |
| Fujii, Y; Inomata, S; Miyabe, M; Takahashi, S; Toyooka, H | 1 |
| Hashimoto, K; Sugiyama, A; Takahara, A | 1 |
| Fujii, Y; Hoshi, T; Inomata, S; Miyabe, M; Takahashi, S; Toyooka, H | 1 |
| Kanki, H; Mitamura, H; Ogawa, S; Sueyoshi, K; Takatsuki, S | 1 |
| Atarashi, H; Endoh, Y; Hayakawa, H; Ino, T; Kuruma, A; Saitoh, H; Yashima, M | 1 |
| Kamiya, H; Tanaka, Y; Watanabe, G; Yasuda, T | 1 |
| Benson, KT; Goto, H; Kindscher, JD; Sasao, J; Taneyama, C; Tarver, SD | 1 |
| Fujita, S; Kanaya, N; Kurosawa, S; Nakayama, M; Namiki, A; Niiyama, Y | 1 |
| Endo, I; Inoue, N; Konishi, R; Maeda, R; Seo, N | 1 |
| Minami, K; Ogata, J; Okamoto, T; Yokoyama, T | 1 |
| Fujii, Y; Hoshi, T; Miyabe, M; Takahashi, S; Toyooka, H; Uemura, A | 1 |
| Mikawa, K; Nishina, K; Sugimoto, Y; Yonemoto, Y | 1 |
| Fujii, G; Kasamatsu, M; Matsuura, A; Miyahara, K; Shimomura, T; Suzuki, S; Yoshida, K | 1 |
| Kamata, K; Morioka, N; Nomura, M; Ozaki, M | 1 |
| Furuhashi, K; Maruyama, K; Suzuki, Y | 1 |
| Igarashi, K; Imai, M; Kanai, M; Miura, K; Okazaki, A; Sakai, H | 1 |
| Akune, T; Chang, KH; Hanaoka, K; Imamura, S; Saitoh, Y; Sano, E | 1 |
| Goto, M; Isomine, S; Kanazawa, T; Mayahara, T; Nakajima, H; Sakaida, K; Sato, M | 1 |
| Fujiya, T; Kimura, M; Ogawa, R; Okubo, Y; Sakamoto, A; Suzuki, H | 1 |
| Hongo, T; Ogawa, R; Sakamoto, A; Yoshida, Y | 1 |
| Baba, S; Fukushi, S; Hirota, K; Matsuki, A; Muraoka, M | 1 |
| Asada, A; Hase, I; Nishikawa, K; Oda, Y | 1 |
| Fujii, K; Hatano, Y; Hironaka, Y; Iranami, H; Kinoshita, H; Nakahata, K; Shimogai, M; Yamazaki, A | 1 |
| Iwasawa, K; Katou, M; Nakagawa, H; Nishizawa, M; Yanagiya, N; Yonezawa, K | 1 |
| Kanoda, T; Kubo, K; Murao, K; Nakao, S; Shingu, K; Yamada, M | 1 |
| Eguchi, S; Iseki, A; Kawano, T; Oshita, S | 1 |
| Goto, K; Hasegawa, A; Hidaka, S; Iwasaka, H; Kitano, T; Kusaka, J; Noguchi, T; Yasuda, N | 1 |
| Kuro, M; Nohmi, T; Ohnishi, Y; Shinzawa, M; Tsuzuki, M | 1 |
| Goto, F; Hiraoka, H; Kunimoto, F; Saito, S; Sato, E; Takizawa, D | 1 |
| Kim, C; Ogawa, R; Sakamoto, A | 1 |
| Hatano, Y; Kakutani, T; Kinoshita, H; Mizumoto, K | 1 |
| Goyagi, T; Nishikawa, T; Tanaka, M | 1 |
| Furuie, H; Irie, S; Kikawa, S; Matsuguma, K; Murakami, M; Wanibuchi, A | 1 |
| Munakata, A; Sakamoto, J; Suto, K; Suto, T; Takahata, T; Tateishi, T; Yasui-Furukori, N | 1 |
| Akihiro, T; Goto, F; Nishihara, F; Nishikawa, K; Obata, H; Saito, S; Yuki, N | 1 |
| Chawla, R; Rathee, S; Sharma, S; Tempe, DK | 1 |
| Fukui, K; Hashiba, E; Hashimoto, H; Hirota, K; Itoh, K; Kushikata, T | 1 |
| Onaka, M; Yamamoto, H | 1 |
| Fukuda, K; Kurita, T; Morita, K; Sanjo, Y; Sato, S; Takata, K; Uraoka, M | 1 |
| Horimoto, H; Horimoto, S; Kishida, K; Mieno, S; Sasaki, S | 1 |
| Mio, Y | 1 |
| Masaki, E | 1 |
| Nomoto, K; Oe, K; Serada, K; Suzuki, T; Yamada, S; Yoshida, T | 1 |
| Azami, T; Hirate, H; Ito, H; Katsuya, H; Sasano, H; So, M; Sobue, K; Sugiura, T | 1 |
| Goyagi, T; Kimura, T; Masaki, Y; Nishikawa, T; Tobe, Y | 1 |
| Kitoh, T; Kobayashi, K; Otagiri, T; Satoh, N | 1 |
| Harasawa, R; Hayashi, Y; Iwasaki, M; Kamibayashi, T; Mashimo, T | 1 |
| Hidaka, K; Masuoka, M; Seki, S; Sugiura, S; Tsuchida, H | 1 |
| Abe, F; Nonaka, A; Suzuki, S | 1 |
| Arita, H; Hanaoka, K; Mizuno, J; Yamada, Y; Yokoyama, T; Yoshiya, I | 1 |
| Fujii, H; Fukushima, T; Ishii, F; Katayama, D; Kawanishi, S; Kosaka, J; Mikane, T; Nagano, Y; Oku, S; Tokioka, H | 1 |
| Iijima, T; Kashimoto, S; Miura, S; Sugawara, T; Zhao, H | 1 |
| Nakagawa, H; Nanba, M; Okayama, Y | 1 |
| Hirai, H; Minamiyama, Y; Sakaguchi, M; Sasaki, Y; Shibata, T; Suehiro, S; Takahashi, Y; Takemura, S | 2 |
| Kurita, T; Morita, K; Sato, S; Takata, K; Uraoka, M | 1 |
| Kim, C; Kitamura, A; Nakanishi, K; Sakamoto, A; Sato, C; Yokozuka, M | 1 |
| Hirata, N; Kamada, N; Kanaya, N; Kimura-Kurosawa, S; Nakayama, M; Namiki, A | 1 |
| Goto, K; Miyakawa, H; Miyamoto, S; Noguchi, T; Shingu, C | 1 |
| Izumi, S; Kakinohana, M; Nakamura, S; Noguchi, N; Sugahara, K | 1 |
| Makita, T; Nishioka, K; Shibata, O; Sumikawa, K; Yamaguchi, M | 1 |
| Akada, S; Hongo, T; Miyagi, Y; Sakamoto, A; Sato, C; Takeda, S; Tanaka, K; Terajima, K; Yoshida, Y | 1 |
| Arita, H; Hanaoka, K; Mizuno, J; Otsuji, M; Tsuda, T | 1 |
| Matsuo, K; Sanui, M; Sunagawa, H | 1 |
| Kawaguchi, M; Kazama, T; Masui, K; Takamatsu, I | 1 |
| Iwasaki, T; Naruo, H; Tsuneyoshi, I; Yano, T | 1 |
| Kadoi, Y; Miyazaki, M; Sawano, Y; Shimada, H; Takashi, S | 1 |
| Higashi, A; Kanmura, Y; Matsunaga, A; Omae, T; Sakata, R; Tsuneyoshi, I | 1 |
| Hosokawa, N; Iwasaki, T; Kasaba, T; Komatsu, M; Shirasaka, T; Takasaki, M | 1 |
| Ishii, H; Isobe, S; Kato, M; Kobayashi, M; Meno, C; Mimura, T; Murohara, T; Sato, K; Sugiura, K | 2 |
| Ishimura, N; Kumano, H; Morioka, M; Nishiwada, M; Okita, T; Shinjo, T; Uji, M | 1 |
| Desaki, Y; Kido, T; Morihara, A; Semba, K; Suzuki, Y; Takasaki, Y; Terao, K | 1 |
| Hagiwara, S; Iwasaka, H; Maeda, H; Noguchi, T | 1 |
| Aoki, M; Fujita, Y; Matsumoto, A; Shimizu, T | 1 |
| Asada, A; Ikeshita, K; Nishikawa, K; Tani, Y; Toriyama, S; Yamada, T; Yamashita, T | 1 |
| Kasuya, S; Kikuchi, C; Saito, N; Tanaka, S | 1 |
| Abe, K; Arai, S; Fukasawa, M; Kawahara, Y; Suzuki, K; Uchida, T | 1 |
| Hashimoto, Y; Miyata, Y; Nago, S; Shibakawa, K; Tsunekawa, M | 1 |
| Hasegawa, C; Hashimoto, Y; Honda, N; Kasai, H; Kikawa, S; Kitagawa, J; Kunisawa, T; Miyata, Y; Nakade, S; Ohno, T; Tanigawara, Y; Yamauchi, A | 1 |
| Ando, Y; Fujinaga, A; Fukusaki, M; Sumikawa, K; Tanabe, T; Terao, Y; Yamashita, K | 1 |
| Dohi, S; Iida, H; Oda, A; Osawa, Y; Tanahashi, S; Yamaguchi, S | 1 |
| Fujiwara, H; Kawamura, T; Namai, A; Sakurai, M | 1 |
| Iwasaki, H; Kunisawa, T; Matsubara, K; Ono, T; Shimizu, K; Suno, M; Tasaki, Y; Yamada, T; Yamagishi, A; Yamamoto, J | 1 |
| Aono, M; Fukano, N; Isaka, T; Miyake, E; Ogawa, S; Saeki, S; Suzuki, T | 1 |
| Asano, N; Ishiyama, T; Matsukawa, T; Sugihara, K | 1 |
| Fukutomi, T; Nishimori, H; Radhakrishnan, G; Sasaguri, S; Wariishi, S; Yamamoto, M; Yamashita, K | 1 |
| Fujikawa, M; Iwasaka, J; Iwasaka, T; Oishi, C; Okazaki, T; Otani, H; Park, H; Sato, D; Ueyama, T; Yamamoto, Y; Yamashita, K | 1 |
| Fujii, M; Fujisawa, H; Ideguchi, M; Ishihara, H; Kajiwara, K; Kato, S; Suzuki, M; Yoshikawa, K | 1 |
| Kadoi, Y; Miyazaki, M; Saito, S | 1 |
| Ichikawa, M; Ishiyama, T; Matsukawa, T; Shibuya, K | 1 |
| Kawamura, T; Namai, A; Sakurai, M; Yoshioka, I | 1 |
| Furuya, H; Inoue, S; Kawaguchi, M; Tanaka, Y | 1 |
| Kurita, T; Nakajima, Y; Sato, S; Suzuki, A; Takata, K; Uraoka, M | 1 |
| Goto, K; Noguchi, T; Ohchi, Y; Shingu, C; Yamamoto, S; Yasuda, N | 1 |
| Goto, K; Hagiwara, S; Hidaka, S; Kusaka, J; Noguchi, T; Shingu, C; Yamamoto, S; Yasuda, N | 1 |
| Iijima, T; Iwao, Y; Kasuya, Y; Tamada, N; Yorozu, T | 1 |
| Katoh, T; Makino, H; Mimuro, S; Okada, H; Sato, S; Yu, S | 1 |
| Kawamoto, M; Saeki, N; Taguchi, S | 1 |
| Goyagi, T; Masaki, Y; Nishikawa, T; Tobe, Y; Umehara, S | 1 |
| Kawaguchi, M; Masui, K; Sakabe, T; Takeda, Y; Uchino, H; Utada, K; Yoshitani, K | 1 |
| Egawa, H; Fujii, K; Hamaguchi, S; Ishikawa, K; Kaneko, M; Kitajima, T; Minami, J; Yamaguchi, S | 1 |
| Ide, M; Kadoi, Y; Miyazaki, M; Saito, S; Sawano, Y; Shimada, H; Takahashi, K | 1 |
| Lefor, A; Sanui, M; Shiotsuka, J | 1 |
| Kasuya, Y; Murakami, T; Oshima, T; Saitoh, Y; Yokota, M | 1 |
| Fujiwara, Y; Harada, J; Ito, H; Kandatsu, N; Kato, N; Komatsu, T; Matsura, M | 1 |
| Tanaka, K | 1 |
| Abe, T; Fukuda, T; Haruna, T; Inoko, M; Ito, H; Miyamoto, S; Nakane, E; Nohara, R; Sasaki, K; Uehara, K; Ueyama, K | 1 |
| Namiki, A; Namiki, M; Tsukakubo, T; Tsumura, N | 1 |
| Abe, A; Hoshida, K; Ikeda, T; Ishiguro, H; Mera, H; Miwa, Y; Miyakoshi, M; Tsukada, T; Yanagisawa, R; Yoshino, H; Yusu, S | 1 |
| Abe, R; Furuya, H; Hayashi, H; Inoue, S; Kawaguchi, M; Kawaraguchi, Y; Nakase, H; Yamamoto, Y | 1 |
| Goyagi, T; Horiguchi, T; Nishikawa, T; Tobe, Y | 1 |
| Abe, R; Furuya, H; Inoue, S; Kawaguchi, M; Kobayashi, H | 2 |
| Hirata, N; Miyashita, R; Watanabe, A; Yamakage, M | 1 |
| Abe, T; Goto, K; Hagiwara, S; Hidaka, S; Noguchi, T; Uchino, T; Yamamoto, S; Yasuda, N | 1 |
| Kurosawa, H; Sato, Y; Seto, Y; Takase, S; Wakamatsu, H; Yokoyama, H | 1 |
| Horiuchi, T; Kadoi, Y; Maruyama, N; Nara, T; Saito, S; Sasaki, M; Satoh, J; Shimada, H; Sugaya, T; Takahashi, K; Uchida, S; Yoshikawa, D | 1 |
| Goyagi, T; Nishikawa, T; Tobe, Y | 2 |
| Horiuchi, T; Kadoi, Y; Saito, S; Uchida, S | 1 |
| Hata, M; Hirayama, A; Minami, K; Nakai, T; Sezai, A; Shiono, M; Wakui, S; Yoshitake, I | 1 |
| Imanaga, K; Inoue, T; Shiga, T; Tsuchida, H; Wajima, Z | 1 |
| Ibe, T; Kamiyoshihara, M; Kawashima, O; Nagashima, T; Nakano, T; Shimizu, K; Takeyoshi, I | 1 |
| Omata, S; Sato, Y; Takase, S; Wakamatsu, H; Watanabe, T; Yokoyama, H | 1 |
| Abe, N; Hanada, K; Higuma, T; Kushibiki, M; Nishizaki, F; Oikawa, K; Okumura, K; Osanai, T; Saito, S; Sukekawa, T; Tomita, H; Yamada, M; Yokota, T | 1 |
| Funakoshi, Y; Maeda, H; Maekura, R; Nojiri, T; Okumura, M; Takeuchi, Y; Yamamoto, K | 1 |
| Okutani, R; Suehiro, K | 1 |
| Yoshiyama, M | 1 |
| Imazuru, T; Ito, S; Jikuya, T; Konishi, T; Matsuzaki, K | 1 |
| Bessho, R; Fujii, M; Ochi, M; Shimizu, K; Takeda, S; Terajima, K | 1 |
| Endo, S; Okamoto, Y; Ono, K; Shibata, S | 1 |
| Hosoda, S; Kasanuki, H; Kitakaze, M; Namiki, A; Sakamoto, A; Takamoto, S | 1 |
| Akaishi, M | 1 |
| Edanaga, M; Kirita, A; Koro, S; Kurihara, M; Mimura, M; Nakayama, Y; Ohsuda, M; Yamakage, M; Yamaya, K | 1 |
| Nishiyama, Y | 1 |
| Fawcett, JP; Gu, J; He, Q; Hu, L; Liu, X; Shi, M; Sun, Y; Yang, Y; Zhao, L | 1 |
| Doi, M; Fukuta, S; Kobayashi, S; Matsuzaki, M; Murakami, W; Nao, T; Okamura, T; Okuda, S; Susa, T; Tanaka, T; Wada, Y; Yamada, J; Yano, M | 1 |
| Hata, H; Hata, M; Kimura, H; Nakata, K; Sezai, A; Shiono, M; Unosawa, S; Wakui, S; Yoshitake, I | 1 |
| Hirai, H; Hosono, M; Morisaki, A; Nakahira, A; Sakaguchi, M; Sasaki, Y; Seo, H; Suehiro, S | 1 |
| Goyagi, T; Horiguchi, T; Masaki, Y; Nishikawa, T; Tobe, Y | 1 |
| Iwasaka, J; Iwasaka, T; Noda, T; Okazaki, T; Otani, H; Park, H; Sato, D; Ueyama, T; Yamamoto, Y | 1 |
| Fukushima, S; Kuratani, T; Miyagawa, S; Nishi, H; Saito, S; Sakaguchi, T; Sawa, Y; Ueno, T; Yoshikawa, Y | 1 |
| Yasumura, Y | 1 |
| Itano, Y; Kaku, R; Kanzaki, H; Matsuoka, Y; Mizobuchi, S; Morita, K; Nishie, H; Obata, N; Ouchida, M; Taniguchi, A; Tomotsuka, N | 1 |
| Adachi, E; Arai, T; Okuda, Y; Saima, S; Shimazaki, M; Tachikawa, M | 1 |
| Aonuma, K; Hoshi, T; Kakefuda, Y; Nishina, H; Noguchi, Y; Sato, A; Wang, Z | 1 |
| Hata, M; Hirayama, A; Kunimoto, S; Nakai, T; Sezai, A; Shiono, M; Yoshitake, I | 1 |
| Aomori, T; Kanamoto, M; Matsumoto, N; Saito, S; Shiga, T; Usui, T; Yamamoto, K | 1 |
| Hasegawa, T; Kadowaki, T; Maruo, A; Matsuhisa, H; Noda, R; Oshima, Y | 1 |
| Hayashida, Y; Ito, N; Kuwahara, G; Minematsu, N; Morishige, N; Nishimi, M; Sukehiro, Y; Tashiro, T; Teratani, H | 1 |
| Akagi, N; Ito, H; Kanazawa, S; Kohno, K; Kusano, K; Miyoshi, T; Morimitsu, Y; Nakamura, K; Osawa, K; Sato, S | 1 |
| Hirai, H; Hosono, M; Nakahira, A; Sakaguchi, M; Sasaki, Y; Seo, H; Suehiro, S | 1 |
| Kim, C; Kohda, S; Nakanishi, K; Sakamoto, A; Takeda, S | 1 |
| Arai, H; Makita, S; Miyagi, N; Nagaoka, E; Tamura, K | 1 |
| Ishido, H; Masutani, S; Nakagawa, R; Saiki, H; Senzaki, H | 1 |
| Momomura, S | 1 |
| Aiba, T; Atarashi, H; Daimon, T; Fujino, K; Hori, M; Ikeda, T; Imai, Y; Inoue, H; Kinugawa, K; Kitakaze, M; Nagai, R; Nagano, T; Okamura, T; Sakamoto, A; Seino, Y; Shimizu, W; Yamashita, T | 2 |
| Abe, M; Hiramatsu, Y; Horigome, H; Kanemoto, S; Sakakibara, Y; Takahashi-Igari, M; Tokunaga, C | 1 |
| Imanaga, K; Inoue, T; Shiga, T; Wajima, Z | 1 |
| Ando, J; Fukuda, T; Kitamura, T; Mitsui, T; Mori, K; Nomura, S; Seto, Y; Shimizu, N; Wada, I; Yamada, K; Yamaguchi, D | 1 |
| Hayata, K; Iida, T; Iwahashi, M; Katsuda, M; Nakamori, M; Nakamura, M; Ojima, T; Yamaue, H | 1 |
| Kikawa, S; Taenaka, N | 2 |
| Plosker, GL | 1 |
| Hara, K; Hirano, M; Iino, M; Ikari, Y; Jinzaki, M; Kuribayashi, S; Suzuki, T; Yamaguchi, T; Yamashina, A | 1 |
| Adachi, T; Aonuma, K; Baba, M; Hasegawa, T; Hiraya, D; Hoshi, T; Kuroki, K; Sato, A | 1 |
| Hifumi, T; Inoue, J; Kato, H; Kiriu, N; Koido, Y; Okada, I | 1 |
| Hua, W; Huang, M; Wang, H; Wang, M; Zhang, Q; Zhou, W | 1 |
| Hamada, C; Hara, K; Hirano, M; Iino, M; Ikari, Y; Jinzaki, M; Kuribayashi, S | 1 |
| Iida, T; Iwasaki, H; Kanda, H; Kunisawa, T; Kurosawa, A; Matsumoto, M; Takahata, O; Takakai, H; Yoshimura, M | 1 |
| Hara, K; Hirano, M; Iino, M; Ikari, Y; Jinzaki, M; Kuribayashi, S; Tanimoto, M; Yamaguchi, T; Yamashina, A | 2 |
| Amenomori, H; Fujii, T; Hashimoto, T; Maruyama, T; Mizunoya, K; Morimoto, Y; Nasu, S; Tanaka, N | 1 |
| Doi, M; Kobayashi, S; Matsuzaki, M; Murakami, W; Myoren, T; Nao, T; Okuda, S; Tateishi, H; Wada, Y; Yano, M | 1 |
| Fujito, K; Fukuda, T; Hirano, M; Igarashi, A | 1 |
| Beldar, S; Beseda, I; Breza, M; Liptaj, T; Rabong, C; Štujber, M | 1 |
| Ishitoya, H; Maisawa, K; Shimamura, Y; Yamazaki, K | 1 |
| Aoki, M; Baba, H; Goto, Y; Ogawa, S; Okawa, Y | 1 |
| Bian, C; Jian, Y; Liu, S; Liu, W; Zhang, Y | 1 |
| Furuichi, Y; Sakamoto, A | 1 |
| Hagiya, K; Islam, MM; Jesmin, S; Kamiyama, J; Kawano, S; Khatun, T; Mizutani, T; Oki, M; Rahman, MA; Sakuramoto, H; Seki, Y; Shimojo, N; Sonobe, A | 1 |
| Kadoi, Y; Saito, S | 1 |
| Hamasaki, T; Kitakaze, M; Sakamoto, A | 1 |
| Hagiya, K; Islam, MM; Jesmin, S; Kamiyama, J; Kawano, S; Khatun, T; Mizutani, T; Ogura, Y; Oki, M; Sakuramoto, H; Shimojo, N; Yamaguchi, N | 1 |
| Birkenhäger, TK; Boere, E; Groenland, TH; van den Broek, WW | 1 |
| Sezai, A; Shiono, M | 1 |
| Higashi, R; Iwasaki, H; Kunisawa, T; Kurosawa, A; Matsubara, K; Nakade, S; Sugawara, A; Suno, M; Yamagishi, A | 1 |
| Kitano, M; Komasawa, N; Minami, T; Sawai, T | 1 |
| Fujitate, Y; Kitano, M; Komasawa, N; Kuzukawa, Y; Minami, T; Nagamine, T | 1 |
| Adachi, YU; Ejima, T; Hatano, T; Matsuda, N; Numaguchi, A; Obata, Y; Sato, S; Suzuki, K | 1 |
| Kamiya, S; Minematsu, N; Morita, Y; Nishimi, M; Osumi, M; Tashiro, T; Wada, H | 1 |
| Deng, X; Guo, Q; He, J; He, P; Lang, Z; Li, S; Tao, G; Wang, X; Xiao, J; Xue, Z; Yang, T; Zhao, Y; Zou, Q | 1 |
| Fujii, T; Fujiwara, M; Iwata, N; Kobayashi, D; Kodera, Y; Koike, M; Nakayama, G; Niwa, Y; Sugimoto, H; Tanaka, C | 1 |
| Matsushita, M; Saitoh, T; Yamashita, T | 1 |
| Azuma, H; Oka, H; Sugimoto, M | 1 |
| Deguchi, S; Fujiwara, S; Kido, H; Komasawa, N; Minami, T | 1 |
| Kurita, T; Morita, K; Sato, S | 2 |
| Abe, M; Akao, M; Hamatani, Y; Iguchi, M; Ishii, M; Masunaga, N; Nakatani, R; Ogawa, H; Takagi, D; Unoki, T; Usui, T; Yamashita, Y | 1 |
| Arimoto, M; Hata, H; Ishii, Y; Osaka, S; Sezai, A; Shiono, M; Yaoita, H | 1 |
| Aoyagi, T; Hayami, N; Inaba, H; Kanamori, K; Kunishima, T; Mikamo, T; Murakawa, Y; Tsutsui, K | 1 |
| Amiya, E; Endo, M; Hatano, M; Imamura, T; Inaba, T; Kinugawa, K; Komuro, I; Maki, H; Nitta, D | 1 |
| Fujita, Y; Miyake, K; Miyazu, M; Sento, Y; Sobue, K; Tomita, M; Yoshimura, S; Yoshizawa, S | 1 |
| Fujino, Y; Ohta, N; Shibata, SC; Uchiyama, A | 1 |
| Tachi, K; Takahashi, S; Tanaka, M | 1 |
| Higashi, M; Hirano, M; Jinzaki, M; Kanzaki, S; Kido, T; Kuribayashi, S; Mochizuki, T; Tanaka, R; Yamada, Y; Yoshioka, K | 1 |
| Kihara, Y; Yamamoto, H | 1 |
| Bai, Y; Chen, Q; Feng, C; Ji, T; Qin, Y; Sun, L; Ye, X; Zhao, X; Zhu, J | 1 |
| Arashi, T; Haruyama, N; Mae, T; Takata, J | 1 |
| Doi, K; Hiruma, T; Inokuchi, R; Nakajima, S; Nakamura, K; Tokunaga, K | 1 |
| Hodisch, J; Kadlecová, P; Krumpl, G; Trebs, M; Ulc, I | 3 |
| Doi, H; Endo, T; Ishigami, T; Ishikawa, T; Iwata, K; Kawashima, C; Kimura, K; Kiyokuni, M; Komura, N; Konishi, M; Mitsuhashi, T; Nakayama, N; Narikawa, M; Sakamaki, K; Sugano, T; Tomari, S; Yamanaka, T; Yano, H | 1 |
| Freissmuth, M; Nanoff, C; Nasrollahi-Shirazi, S; Sucic, S; Yang, Q | 1 |
| Hakone, M; Kasuya, Y; Motoyasu, A; Yamada, T; Yorozu, T | 1 |
| Aoyama, H; Aoyama, Y; Otsuka, Y | 1 |
| Akhtar, S; Hideaki, S; Hizawa, N; Inoue, Y; Jesmin, S; Kawano, S; Khatun, T; Kiwamoto, T; Matsuishi, Y; Mizutani, T; Mowa, CN; Shimojo, N; Tsunoda, Y; Zaedi, S | 1 |
| Akasaka, M; Araya, N; Asami, M; Chida, S; Furukawa, H; Ishikawa, K; Kamei, A; Nasu, Y; Oyama, K; Takada, A; Tanifuji, S | 1 |
| Horigome, H; Iwamoto, M; Miura, M; Miyazaki, A; Nagano, T; Ohashi, N; Ono, H; Sagawa, K; Sakaguchi, H; Sumitomo, N; Suzuki, T; Takahashi, K; Takamuro, M; Takigiku, K; Tokunaga, C; Ueda, H; Ushinohama, H; Yoshimoto, J | 1 |
| Goyagi, T; Horiguchi, T; Horikoshi, Y; Kodama, S; Kudo, R; Nishikawa, T | 1 |
| Hodisch, J; Husch, B; Kadlecová, P; Krumpl, G; Maurer, G; Trebs, M; Ulč, I | 2 |
| Hayata, K; Kato, T; Katsuda, M; Kitadani, J; Nakamori, M; Nakamura, M; Ojima, T; Tabata, H; Takeuchi, A; Yamaue, H | 1 |
| Kawashima, S; Kurita, T; Morita, K; Nakajima, Y | 3 |
| Fujita, M; Godo, S; Kawazoe, Y; Kudo, D; Kushimoto, S; Nomura, R; Ozaki, H; Shimokawa, H | 1 |
| Tamura, T; Yatabe, T; Yokoyama, M | 1 |
| Arita, Y; Hasegawa, S; Segawa, T; Yamamoto, S | 1 |
| Arakawa, S; Kawano, H; Maemura, K; Matsumoto, Y; Sato, O; Yamasa, T | 2 |
| Fitzgerald, RD; Frank, G | 1 |
| Landoni, G; Monaco, F; Poveda-Jaramillo, R; Zangrillo, A | 1 |
| Syed, YY | 1 |
| Kugo, Y; Nishi, H; Sekiya, N; Takahashi, T; Yamada, M | 1 |
| Takahashi, S; Tanaka, M; Yamada, M; Yamashita, S | 1 |
| Bernard, M; Desrois, M; Fourny, N; Iché-Torres, M; Kober, F; Lalevée, N; Lan, C; Lê, LT; Leone, M; Mathieu, C; Mège, JL; Singer, M; Tran, TT | 1 |
| Hiramatsu, Y; Kato, H; Mathis, BJ; Nakajima, T; Sakamoto, H; Tokunaga, C; Yoneyama, F | 1 |
| Madias, JE | 1 |
| Akhtar, K; Asaad, P; Hajibandeh, S; Melhado, R; Trivedi, V | 1 |
| Kawada, T; Li, M; Sugimachi, M; Uemura, K; Zheng, C | 1 |
| Kobayashi, Y; Ogiwara, K; Yasumura, R | 1 |
| Biancofiore, G; Bouvet, O; Cerny, V; Dostál, P; Girardis, M; Grohmann-Izay, B; Guarracino, F; Heinz, G; Joannidis, M; Kadlecova, P; Klade, C; Krejcy, K; Krumpl, G; Morelli, A; Pratesi, F; Radermacher, P; Rehberg, S; Siebers, C; Singer, M; Trimmel, H; Unger, M; Zörer, M | 1 |
| Kanmura, Y; Kiyonaga, N; Moriyama, T | 1 |
| Fujimoto, Y; Hayashi, H; Hayashi, M; Ito-Hagiwara, K; Iwasaki, YK; Maru, E; Oka, E; Shimizu, W; Yamamoto, T; Yodogawa, K | 1 |
| Harada, T; Okamura, T; Sakamoto, A; Usuda, J; Yagi, K | 1 |
| Daimon, T; Ikeda, T; Kinugawa, K; Nagai, R; Okamoto, H; Oki, K; Sakamoto, A; Shiga, T; Shimizu, W; Yamashita, T | 1 |
| Imamura, T; Nitta, D | 1 |
| Iwasaki, YK; Oka, E; Shimizu, W | 1 |
| Mizutani, H; Nakasu, Y; Sumitani, K; Yamashita, T | 1 |
| Jujo, S; Kamei, M; Kobayashi, J; Ohnishi, Y; Sakai, M | 1 |
| Er, F; Gassanov, N | 1 |
| Fujita, S; Futatani, T; Hatasaki, K; Nakagawa, R; Shimao, A | 1 |
| Domanovits, H; Hodisch, J; Husch, B; Kadlecová, P; Krumpl, G; Stix, G; Trebs, M; Unger, M; Wolzt, M | 1 |
| Aragaki, M; Hamasaki, T; Hida, Y; Horie, N; Nojiri, T; Onda, K; Sato, N; Yamamoto, H | 1 |
| Heringlake, M; Walter, E | 1 |
| Muehlschlegel, JD; O'Brien, B | 1 |
| Dabrowski, W; Jaroszynski, A; Piasek, E; Schlegel, TT; Siwicka-Gieroba, D | 1 |
| Kakihana, Y; Matsuda, N; Morimatsu, H; Morishima, E; Nagano, T; Nishida, O; Ogura, H; Okajima, M; Taniguchi, T; Yamada, Y | 1 |
| Morelli, A; Rehberg, S; Whitehouse, T | 1 |
| Inoue, Y; Kawano, S; Mathis, BJ; Matsuishi, Y; Shimojo, N | 1 |
| Akiyama, M; Ito, K; Kaiho, Y; Katahira, S; Kumagai, K; Maeda, K; Matsuo, S; Saiki, Y; Sasaki, K; Sugawara, Y; Suzuki, T; Suzuki, Y; Tsuji, I | 1 |
| Ishigami, T; Ishikawa, T; Iwata, K; Kimura, K; Kiyokuni, M; Komura, N; Konishi, M; Nakayama, N; Saigusa, Y; Sugano, T; Tamura, K; Yamanaka, T | 1 |
| Imamura, T; Kinugawa, K | 1 |
| Akitsu, K; Fujino, T; Ikeda, T; Kinoshita, T; Koike, H; Shinohara, M; Suzuki, T; Wada, R; Yano, K | 1 |
| Ait-Oufella, H; Baudel, JL; Bige, N; Hariri, G; Mazerand, S; Urbina, T | 1 |
| Bion, J; Boota, N; Gates, S; Gordon, AC; Lall, R; Lord, J; McAuley, DF; Mistry, D; Perkins, G; Regan, S; Singer, M; Skilton, E; Whitehouse, T; Young, D | 1 |
| Enomoto, D; Hyodo, T; Ikeda, S; Okura, T; Sakaue, T; Takahashi, K; Takemoto, M; Uemura, S; Utsunomiya, Y; Yamashita, M | 1 |
| Allaouchiche, B; Cazenave, L; Fellahi, JL; Ferraris, A; Fornier, W; Jacquet-Lagrèze, M; Jalalzai, W; Junot, S; Pozzi, M; Rousseau-Saine, N | 1 |
| Ashida, A; Kishi, K; Konishi, H; Nemoto, S; Odanaka, Y; Ozaki, N | 1 |
| Hirano, M; Nagano, T; Nonaka, S; Okamura, T; Shiroya, T | 1 |
| Ichikawa, K; Ito, H; Miyamoto, M; Miyoshi, T; Mori, A; Nakamura, K; Oka, T; Osawa, K; Yoshikawa, M | 1 |
| Chen, C; Hao, J; Liu, L; Peng, H; Xu, W; Zhang, J; Zhou, J | 1 |
| Egashira, T; Hara, T; Higashijima, U; Ichinomiya, T; Ishizaki, H; Matsumoto, S; Ogami-Takamura, K; Sekino, M; Yano, R; Yokoyama, A | 1 |
| Abe, T; Ebina, T; Hanajima, Y; Hibi, K; Horii, M; Iwahashi, N; Kimura, K; Kimura, Y; Kirigaya, J; Kosuge, M; Matsuzawa, Y; Minamimoto, Y; Okada, K; Takahashi, H; Tamura, K | 1 |
| Hodisch, J; Husch, B; Kadlecová, P; Krumpl, G; Trebs, M; Ulč, I | 1 |
| Colombo, C; Ditali, V; Garatti, L; Morici, N; Oliva, F; Sacco, A; Villanova, L | 1 |
| Fejér, C; Gellér, L; Kiss, B; Kovács, E; Merkely, B; Pilecky, D; Radics, P; Ruzsa, Z; Straub, É; Zima, E | 1 |
| Cazenave, L; Fellahi, JL; Ferraris, A; Fornier, W; Jacquet-Lagrèze, M; Jalalzai, W; Pozzi, M; Rousseau-Saine, N | 1 |
| Aoki, H; Fukunaga, H; Horigome, H; Miura, M; Miyazaki, A; Morishima, E; Ohashi, N; Oki, K; Ono, H; Sagawa, K; Sakaguchi, H; Sato, S; Sumitomo, N; Suzuki, T; Takei, K; Ueda, H | 1 |
| Ackerl, J; Dresbach, T; Kipfmueller, F; Monno, P; Mueller, A; Schmitt, J; Schroeder, L; Shatilova, O; Unger, M | 1 |
| Katsube, T; Kawakami, A; Kobayashi, Y | 1 |
| Chalkias, A; O'Donnell, EP | 1 |
20 review(s) available for urea and landiolol
| Article | Year |
|---|---|
[Landiolol hydrochloride, a new sympathetic beta blocker].
Topics: Adrenergic beta-Antagonists; Anesthesia, General; Clinical Trials as Topic; Humans; Morpholines; Tachycardia; Urea | 1998 |
[New ultra-short-acting beta-blockers: landiolol and esmolol--the effects on cardiovascular system].
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Cardiovascular System; Heart Rate; Humans; Morpholines; Myocardial Ischemia; Propanolamines; Urea | 2006 |
[Antinociceptive effects of landiolol and esmolol].
Topics: Adjuvants, Anesthesia; Adrenergic beta-Antagonists; Analgesics; Animals; Humans; Intubation, Intratracheal; Morpholines; Propanolamines; Urea | 2006 |
[Assessment by logistic model of hemodynamic changes during general anesthesia].
Topics: Adrenergic Antagonists; Anesthesia, General; Diastole; Female; Heart Rate; Hemodynamics; Humans; Infusions, Intravenous; Intraoperative Care; Logistic Models; Male; Monitoring, Intraoperative; Morpholines; Systole; Urea | 2008 |
The efficacy of landiolol for suppressing the hyperdynamic response following laryngoscopy and tracheal intubation: a systematic review.
Topics: Adrenergic beta-Antagonists; Blood Pressure; Dose-Response Relationship, Drug; Heart Rate; Hemodynamics; Humans; Intubation, Intratracheal; Japan; Laryngoscopy; Morpholines; Randomized Controlled Trials as Topic; Urea | 2009 |
Landiolol: a review of its use in intraoperative and postoperative tachyarrhythmias.
Topics: Animals; Humans; Intraoperative Complications; Morpholines; Postoperative Complications; Randomized Controlled Trials as Topic; Tachycardia; Urea | 2013 |
Landiolol hydrochloride for prevention of atrial fibrillation after cardiac surgery: a meta-analysis.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Surgical Procedures; Humans; Incidence; Morpholines; Postoperative Complications; Premedication; Risk Factors; Survival Rate; Treatment Outcome; Urea | 2014 |
[Perioperative cardiovascular evaluation and management for noncardiac surgery].
Topics: Adrenergic beta-Antagonists; Anesthesia; Atenolol; Bisoprolol; Fatty Acids, Monounsaturated; Fluvastatin; Humans; Indoles; Intraoperative Complications; Metoprolol; Monitoring, Intraoperative; Morpholines; Myocardial Infarction; Myocardial Ischemia; Perioperative Care; Postoperative Complications; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Risk Assessment; Urea | 2014 |
Perioperative landiolol administration reduces atrial fibrillation after cardiac surgery: A meta-analysis of randomized controlled trials.
Topics: Adrenergic beta-Antagonists; Atrial Fibrillation; Cardiac Surgical Procedures; Humans; Incidence; Japan; Morpholines; Postoperative Complications; Randomized Controlled Trials as Topic; Treatment Outcome; Urea | 2014 |
Beta-blocking agents during electroconvulsive therapy: a review.
Topics: Adrenergic beta-Antagonists; Cardiovascular Diseases; Electroconvulsive Therapy; Humans; Labetalol; Morpholines; Propanolamines; Randomized Controlled Trials as Topic; Urea | 2014 |
Are beta-blockers effective for preventing post-coronary artery bypass grafting atrial fibrillation? Direct and network meta-analyses.
Topics: Adrenergic beta-Antagonists; Atrial Fibrillation; Bayes Theorem; Bisoprolol; Coronary Artery Bypass; Humans; Incidence; Morpholines; Network Meta-Analysis; Randomized Controlled Trials as Topic; Urea | 2016 |
Prevention of atrial fibrillation after cardiac surgery using low-dose landiolol: A systematic review and meta-analysis.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Atrial Fibrillation; Coronary Artery Bypass; Dose-Response Relationship, Drug; Hospital Mortality; Humans; Incidence; Morpholines; Odds Ratio; Perioperative Care; Postoperative Complications; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Treatment Outcome; Urea | 2017 |
Ultra-Short-Acting β-Blockers (Esmolol and Landiolol) in the Perioperative Period and in Critically Ill Patients.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Cardiac Surgical Procedures; Critical Illness; Heart Rate; Humans; Morpholines; Myocardial Ischemia; Perioperative Period; Propanolamines; Urea | 2018 |
Landiolol: A Review in Tachyarrhythmias.
Topics: Administration, Intravenous; Adrenergic beta-1 Receptor Antagonists; Atrial Fibrillation; Dose-Response Relationship, Drug; Drug Approval; Heart Failure; Heart Rate; Humans; Japan; Morpholines; Tachycardia; Tachycardia, Supraventricular; Treatment Outcome; Urea; Ventricular Dysfunction, Left | 2018 |
[The Role of Ultrarapid Acting Betablocker Esmolol and Landiolol in Critically Ill Patients].
Topics: Adrenergic beta-Antagonists; Atrial Fibrillation; Critical Illness; Humans; Morpholines; Propanolamines; Urea | 2019 |
Cost-Effectiveness Analysis of Landiolol, an Ultrashort-Acting Beta-Blocker, for Prevention of Postoperative Atrial Fibrillation for the Germany Health Care System.
Topics: Atrial Fibrillation; Cost-Benefit Analysis; Delivery of Health Care; Germany; Humans; Morpholines; Postoperative Complications; Urea | 2020 |
Evaluating the Therapeutic Efficacy and Safety of Landiolol Hydrochloride for Management of Arrhythmia in Critical Settings: Review of the Literature.
Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Critical Care; Female; Heart Rate; Humans; Male; Morpholines; Risk Factors; Treatment Outcome; Urea; Young Adult | 2020 |
Novel rate control strategy with landiolol in patients with cardiac dysfunction and atrial fibrillation.
Topics: Atrial Fibrillation; Humans; Japan; Morpholines; Urea | 2020 |
Beta-Blocker Landiolol Hydrochloride in Preventing Atrial Fibrillation Following Cardiothoracic Surgery: A Systematic Review and Meta-Analysis.
Topics: Atrial Fibrillation; Humans; Morpholines; Postoperative Complications; Treatment Outcome; Urea | 2022 |
Mechanisms of landiolol-mediated positive inotropy in critical care settings.
Topics: Adrenergic beta-Antagonists; Animals; Critical Care; Critical Illness; Heart Failure; Heart Rate; Humans; Urea | 2023 |
83 trial(s) available for urea and landiolol
| Article | Year |
|---|---|
Efficacy of an ultrashort-acting beta-adrenoceptor blocker (ONO-1101) in attenuating cardiovascular responses to endotracheal intubation.
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Female; Heart Rate; Hemodynamics; Humans; Intubation, Intratracheal; Laryngoscopy; Male; Middle Aged; Morpholines; Urea | 1997 |
Pharmacokinetics of landiolol hydrochloride, a new ultra-short-acting beta-blocker, in patients with cardiac arrhythmias.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Morpholines; Tachycardia, Supraventricular; Tachycardia, Ventricular; Urea; Ventricular Premature Complexes | 2000 |
Landiolol attenuates acute hemodynamic responses but does not reduce seizure duration during maintenance electroconvulsive therapy.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Anesthesia; Anesthesia Recovery Period; Cross-Over Studies; Depressive Disorder; Double-Blind Method; Electroconvulsive Therapy; Female; Hemodynamics; Humans; Male; Middle Aged; Morpholines; Psychometrics; Seizures; Urea | 2004 |
Efficacy of landiolol in attenuating hemodynamic responses to local epinephrine infiltration in patients undergoing vaginal total hysterectomy.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Anesthesia, General; Blood Pressure; Epinephrine; Female; Heart Rate; Hemodynamics; Humans; Hysterectomy, Vaginal; Middle Aged; Morpholines; Urea | 2005 |
The short-acting beta1-adrenoceptor antagonists esmolol and landiolol suppress the bispectral index response to tracheal intubation during sevoflurane anesthesia.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Double-Blind Method; Electroencephalography; Female; Heart Rate; Humans; Intubation, Intratracheal; Male; Methyl Ethers; Middle Aged; Morpholines; Propanolamines; Sevoflurane; Urea | 2005 |
Landiolol attenuates tachycardia in response to endotracheal intubation without affecting blood pressure.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Double-Blind Method; Heart Rate; Humans; Intubation, Intratracheal; Middle Aged; Morpholines; Urea | 2005 |
[Effects of landiolol on cardiovascular responses, bispectral index and body movement during endotracheal intubation].
Topics: Adrenergic beta-Antagonists; Adult; Anesthetics, Intravenous; Blood Pressure; Double-Blind Method; Female; Heart Rate; Hemodynamics; Humans; Intubation, Intratracheal; Male; Middle Aged; Morpholines; Movement; Propofol; Surgical Procedures, Operative; Urea | 2005 |
Influence of landiolol on the dose requirement of propofol for induction of anesthesia.
Topics: Adult; Anesthesia; Anesthetics, Intravenous; Blood Pressure; Cardiac Output; Dose-Response Relationship, Drug; Drug Interactions; Female; Heart Rate; Humans; Infusions, Intravenous; Male; Middle Aged; Morpholines; Patient Selection; Propofol; Urea | 2005 |
Landiolol attenuates the cardiovascular response to tracheal intubation.
Topics: Adrenergic beta-Antagonists; Adult; Anesthesia, General; Anesthetics, Intravenous; Blood Pressure; Cardiovascular System; Heart Rate; Humans; Intubation, Intratracheal; Middle Aged; Morpholines; Preanesthetic Medication; Propofol; Prospective Studies; Urea | 2005 |
Pharmacokinetics and pharmacodynamics of landiolol hydrochloride, an ultra short-acting beta1-selective blocker, in a dose escalation regimen in healthy male volunteers.
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Dose-Response Relationship, Drug; Double-Blind Method; Heart Rate; Humans; Male; Morpholines; Urea | 2005 |
Influence of hepatic impairment on the pharmacokinetics and pharmacodynamics of landiolol hydrochloride, an ultra-short-acting beta1-blocker.
Topics: Adrenergic beta-Antagonists; Aged; Female; Heart Rate; Humans; Infusions, Intravenous; Liver Diseases; Male; Metabolic Clearance Rate; Middle Aged; Morpholines; Receptors, Adrenergic, beta-1; Urea | 2005 |
Landiolol and esmolol prevent tachycardia without altering cerebral blood flow.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Anesthesia; Blood Pressure; Cerebrovascular Circulation; Cross-Over Studies; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Electroconvulsive Therapy; Female; Heart Rate; Humans; Male; Middle Aged; Morpholines; Propanolamines; Tachycardia; Ultrasonography, Doppler, Transcranial; Urea | 2005 |
Effects of landiolol on hemodynamic response and seizure duration during electroconvulsive therapy.
Topics: Adrenergic beta-Antagonists; Aged; Anesthetics, Intravenous; Blood Pressure; Cross-Over Studies; Double-Blind Method; Electroconvulsive Therapy; Female; Heart Rate; Humans; Male; Middle Aged; Morpholines; Neuromuscular Depolarizing Agents; Propofol; Prospective Studies; Seizures; Sodium Chloride; Succinylcholine; Time Factors; Urea | 2006 |
Bolus administration of landiolol, a short-acting, selective beta1-blocker, to treat tachycardia during anesthesia: a dose-dependent study.
Topics: Adrenergic beta-Antagonists; Adult; Analysis of Variance; Anesthesia, General; Blood Pressure; Brain Neoplasms; Dose-Response Relationship, Drug; Female; Heart Rate; Humans; Injections, Intravenous; Male; Middle Aged; Morpholines; Prospective Studies; Tachycardia; Time Factors; Treatment Outcome; Urea | 2006 |
The hemodynamic effects of landiolol, an ultra-short-acting beta1-selective blocker, on endotracheal intubation in patients with and without hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Arthroplasty, Replacement, Hip; Blood Pressure; Female; Fentanyl; Heart Rate; Humans; Hypertension; Hypotension; Intubation, Intratracheal; Male; Middle Aged; Morpholines; Receptors, Adrenergic, beta-1; Tachycardia; Urea | 2007 |
The effect of landiolol on hemodynamics and left ventricular function in patients with coronary artery disease.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Blood Pressure; Cardiac Output; Catheterization, Swan-Ganz; Coronary Artery Bypass, Off-Pump; Coronary Artery Disease; Echocardiography, Transesophageal; Female; Heart Rate; Humans; Male; Middle Aged; Morpholines; Prospective Studies; Stroke Volume; Thermodilution; Urea; Ventricular Function, Left | 2007 |
Effect of landiolol on bispectral index and spectral entropy responses to tracheal intubation during propofol anaesthesia.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Anesthetics, Intravenous; Double-Blind Method; Electroencephalography; Entropy; Female; Humans; Intubation, Intratracheal; Male; Middle Aged; Monitoring, Intraoperative; Morpholines; Piperidines; Propofol; Remifentanil; Signal Processing, Computer-Assisted; Urea | 2008 |
Comparative effects of propofol, landiolol, and nicardipine on hemodynamic and bispectral index responses to endotracheal intubation: a prospective, randomized, double-blinded study.
Topics: Adjuvants, Anesthesia; Aged; Anesthesia, General; Anesthetics, Intravenous; Anti-Arrhythmia Agents; Double-Blind Method; Electroencephalography; Hemodynamics; Humans; Intubation, Intratracheal; Middle Aged; Morpholines; Nicardipine; Propofol; Prospective Studies; Urea; Vasodilator Agents | 2008 |
Effects of landiolol on the cardiovascular response during tracheal extubation.
Topics: Adolescent; Adult; Aged; Anesthesia Recovery Period; Anti-Arrhythmia Agents; Blood Pressure; Female; Heart Rate; Humans; Intubation, Intratracheal; Male; Middle Aged; Morpholines; Time Factors; Urea; Young Adult | 2008 |
Use of landiolol hydrochloride, a new beta-blocker, in coronary computed tomography angiography.
Topics: Adrenergic beta-Antagonists; Aged; Coronary Angiography; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Morpholines; Tomography, X-Ray Computed; Urea | 2010 |
Feasibility of intravenous administration of landiolol hydrochloride for multislice computed tomography coronary angiography: initial experience.
Topics: Aged; Anti-Arrhythmia Agents; Blood Pressure; Coronary Angiography; Coronary Artery Disease; Coronary Stenosis; Female; Heart Rate; Humans; Male; Middle Aged; Morpholines; Tomography, X-Ray Computed; Urea | 2008 |
Population pharmacokinetics of landiolol hydrochloride in healthy subjects.
Topics: Adult; Dose-Response Relationship, Drug; Humans; Male; Morpholines; Pilot Projects; Population; Reproducibility of Results; Urea; Young Adult | 2008 |
Landiolol, a new ultra-short-acting beta1-blocker, reduces anaesthetic requirement during sevoflurane/N(2)O/fentanyl anaesthesia in surgical patients.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Anesthesia; Anesthetics; Female; Fentanyl; Hip; Humans; Male; Methyl Ethers; Middle Aged; Morpholines; Nitrous Oxide; Sevoflurane; Time Factors; Urea | 2009 |
Effect of landiolol hydrochloride on suxamethonium-induced neuromuscular block.
Topics: Adrenergic beta-Antagonists; Adult; Anesthesia Recovery Period; Electric Stimulation; Female; Gynecologic Surgical Procedures; Humans; Middle Aged; Morpholines; Muscle, Skeletal; Neuromuscular Blockade; Neuromuscular Depolarizing Agents; Preanesthetic Medication; Succinylcholine; Ulnar Nerve; Urea | 2009 |
Effects of landiolol, a short-acting beta-1 blocker, on hemodynamic variables during emergence from anesthesia and tracheal extubation in elderly patients with and without hypertension.
Topics: Adrenergic beta-Antagonists; Aged; Anesthesia Recovery Period; Blood Pressure; Electroencephalography; Female; Gynecologic Surgical Procedures; Heart Rate; Hemodynamics; Humans; Hypertension; Intubation, Intratracheal; Male; Monitoring, Intraoperative; Morpholines; Orthopedic Procedures; Urea | 2009 |
The effect of landiolol on cerebral blood flow in patients undergoing off-pump coronary artery bypass surgery.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Cerebrovascular Circulation; Coronary Artery Bypass, Off-Pump; Female; Heart Rate; Hemodynamics; Humans; Infusions, Intravenous; Intraoperative Complications; Male; Middle Aged; Middle Cerebral Artery; Morpholines; Severity of Illness Index; Stroke Volume; Tachycardia; Ultrasonography, Doppler, Transcranial; Urea | 2010 |
Effects of a short-acting [beta]1 receptor antagonist landiolol on hemodynamics and tissue injury markers in patients with subarachnoid hemorrhage undergoing intracranial aneurysm surgery.
Topics: Adrenergic beta-Antagonists; Aged; Biomarkers; Blood Gas Analysis; Blood Pressure; Brain; Electrocardiography; Female; Heart Diseases; Heart Rate; Hemodynamics; Humans; Intraoperative Care; Male; Middle Aged; Morpholines; Nerve Growth Factors; Neurosurgical Procedures; Receptors, Adrenergic, beta-1; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Subarachnoid Hemorrhage; Urea | 2010 |
Effects of landiolol on QT interval and QT dispersion during induction of anesthesia using computerized measurement.
Topics: Adrenergic beta-Antagonists; Adult; Anesthesia; Anesthesiology; Blood Pressure; Double-Blind Method; Electrocardiography; Female; Heart; Humans; Intubation, Intratracheal; Male; Medical Records Systems, Computerized; Middle Aged; Morpholines; Treatment Outcome; Urea; Young Adult | 2009 |
Effects of landiolol on left ventricular function during electroconvulsive therapy: a transthoracic echocardiographic study.
Topics: Adrenergic beta-Antagonists; Aged; Depression; Echocardiography; Electroconvulsive Therapy; Hemodynamics; Humans; Morpholines; Urea; Ventricular Function, Left | 2010 |
Inhibitory effects of landiolol and nicardipine on thiopental-induced yawning in humans.
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Calcium Channel Blockers; Double-Blind Method; Female; Heart Rate; Humans; Hypnotics and Sedatives; Male; Middle Aged; Morpholines; Nicardipine; Thiopental; Urea; Yawning | 2010 |
Prolongation of QT interval induced by electroconvulsive therapy is attenuated by landiolol.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Anesthesia, Intravenous; Anesthetics, Intravenous; Anti-Arrhythmia Agents; Blood Pressure; Depressive Disorder; Electroconvulsive Therapy; Female; Heart Rate; Humans; Long QT Syndrome; Male; Middle Aged; Monitoring, Physiologic; Morpholines; Neuromuscular Depolarizing Agents; Premedication; Propofol; Succinylcholine; Urea | 2010 |
Effects of landiolol, an ultra-short-acting beta1-selective blocker, on electrical storm refractory to class III antiarrhythmic drugs.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Drug Resistance; Female; Heart Rate; Humans; Male; Middle Aged; Morpholines; Tachycardia, Ventricular; Urea | 2010 |
Effects of landiolol on systemic and cerebral hemodynamics and recovery from anesthesia in patients undergoing craniotomy.
Topics: Adrenergic beta-Antagonists; Aged; Anesthesia; Brain; Craniotomy; Female; Hemodynamics; Humans; Male; Middle Aged; Morpholines; Prospective Studies; Urea | 2010 |
Low-dose continuous infusion of landiolol can reduce adrenergic response during tracheal intubation in elderly patients with cardiovascular disease.
Topics: Adrenergic beta-Antagonists; Aged; Anesthesia, General; Autonomic Nervous System Diseases; Blood Pressure; Cardiovascular Diseases; Female; Heart Rate; Hemodynamics; Humans; Infusions, Intravenous; Intubation, Intratracheal; Male; Morpholines; Oxygen; Urea | 2010 |
Beta blocker infusion decreases the magnitude of core hypothermia after anesthesia induction.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Anesthesia, Inhalation; Body Temperature; Coloring Agents; Female; Gynecologic Surgical Procedures; Hemodynamics; Humans; Hypothermia; Indocyanine Green; Intubation, Intratracheal; Middle Aged; Morpholines; Propanolamines; Urea | 2010 |
Landiolol hydrochloride for prevention of atrial fibrillation after coronary artery bypass grafting: new evidence from the PASCAL trial.
Topics: Adrenergic beta-Antagonists; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Coronary Artery Bypass; Cost-Benefit Analysis; Double-Blind Method; Drug Costs; Female; Heart Rate; Hospital Costs; Humans; Japan; Logistic Models; Male; Middle Aged; Morpholines; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Urea | 2011 |
Intravenous landiolol, a novel β(1)-adrenergic blocker, reduces the minimum alveolar concentration of sevoflurane in women.
Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Anesthetics, Inhalation; Elective Surgical Procedures; Female; Hospitals, University; Humans; Methyl Ethers; Middle Aged; Morpholines; Prospective Studies; Pulmonary Alveoli; Sevoflurane; Single-Blind Method; Urea; Young Adult | 2011 |
Randomized study on the efficacy and safety of landiolol, an ultra-short-acting β1-adrenergic blocker, in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.
Topics: Adrenergic beta-1 Receptor Antagonists; Angioplasty, Balloon, Coronary; Combined Modality Therapy; Female; Humans; Injections, Intravenous; Male; Middle Aged; Morpholines; Myocardial Infarction; Prospective Studies; Stroke Volume; Treatment Outcome; Urea; Ventricular Remodeling | 2012 |
Landiolol attenuates cardiovascular response at induction of general anesthesia for cesarean delivery.
Topics: Adrenergic beta-Antagonists; Adult; Anesthesia, General; Anesthesia, Obstetrical; Blood Pressure; Cesarean Section; Female; Heart Rate; Humans; Hypertension; Intubation, Intratracheal; Methyl Ethers; Morpholines; Pregnancy; Sevoflurane; Tachycardia; Urea | 2012 |
Effect of postoperative landiolol administration for atrial fibrillation after off pump coronary artery bypass surgery.
Topics: Adrenergic beta-Antagonists; Aged; Atrial Fibrillation; Coronary Artery Bypass, Off-Pump; Coronary Artery Disease; Dose-Response Relationship, Drug; Electrocardiography; Female; Follow-Up Studies; Heart Rate; Humans; Injections, Intravenous; Male; Morpholines; Postoperative Care; Postoperative Complications; Prospective Studies; Treatment Outcome; Urea | 2012 |
Landiolol, an ultra-short-acting β₁-blocker, more effectively terminates atrial fibrillation than diltiazem after open heart surgery: prospective, multicenter, randomized, open-label study (JL-KNIGHT study).
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Atrial Fibrillation; Cardiac Surgical Procedures; Cardiovascular Agents; Diltiazem; Female; Humans; Male; Middle Aged; Morpholines; Postoperative Complications; Prospective Studies; Urea | 2012 |
[Effect of landiolol on bispectral index scores in patients undergoing lower abdominal surgery].
Topics: Adrenergic beta-Antagonists; Adult; Anesthesia; Consciousness Monitors; Female; Humans; Hysterectomy; Methyl Ethers; Middle Aged; Morpholines; Piperidines; Remifentanil; Sevoflurane; Urea | 2012 |
Intracoronary followed by intravenous administration of the short-acting β-blocker landiolol prevents myocardial injury in the face of elective percutaneous coronary intervention.
Topics: Adrenergic beta-Antagonists; Aged; Elective Surgical Procedures; Female; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Male; Middle Aged; Morpholines; Myocardial Infarction; Percutaneous Coronary Intervention; Time Factors; Urea | 2013 |
[Effect of landiolol and combined use of landiolol and olprinone on hemodynamics in patients undergoing off-pump coronary artery bypass grafting].
Topics: Adrenergic beta-Antagonists; Aged; Coronary Artery Bypass, Off-Pump; Female; Hemodynamics; Humans; Imidazoles; Male; Morpholines; Phosphodiesterase 3 Inhibitors; Pyridones; Urea | 2012 |
Feasibility of landiolol and bisoprolol for prevention of atrial fibrillation after coronary artery bypass grafting: a pilot study.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Anti-Inflammatory Agents; Antioxidants; Arginine; Atrial Fibrillation; Biomarkers; Bisoprolol; C-Reactive Protein; Coronary Artery Bypass; Creatine Kinase, MB Form; Drug Administration Schedule; Fatty Acid Binding Protein 3; Fatty Acid-Binding Proteins; Female; Hemodynamics; Humans; Infusions, Intravenous; Japan; Male; Middle Aged; Morpholines; Natriuretic Peptide, Brain; Pilot Projects; Serum Amyloid P-Component; Single-Blind Method; Time Factors; Treatment Outcome; Troponin I; Urea | 2012 |
Safety and efficacy of an ultrashort-acting β1-blocker on left ventricular dysfunction.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Atrial Fibrillation; Coronary Artery Bypass; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Morpholines; Premedication; Urea; Ventricular Dysfunction, Left | 2012 |
Safety and efficacy of a bolus injection of landiolol hydrochloride as a premedication for multidetector-row computed tomography coronary angiography.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Coronary Angiography; Female; Heart Rate; Humans; Male; Middle Aged; Morpholines; Multidetector Computed Tomography; Retrospective Studies; Time Factors; Urea | 2013 |
Efficacy of landiolol hydrochloride for prevention of atrial fibrillation after heart valve surgery.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Heart Rate; Heart Valve Prosthesis Implantation; Humans; Infusions, Intravenous; Male; Morpholines; Postoperative Complications; Prospective Studies; Treatment Outcome; Urea | 2012 |
Prevention of atrial fibrillation with ultra-low dose landiolol after off-pump coronary artery bypass grafting.
Topics: Adrenergic beta-Antagonists; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Chi-Square Distribution; Coronary Artery Bypass, Off-Pump; Diltiazem; Female; Hemodynamics; Humans; Incidence; Japan; Male; Middle Aged; Morpholines; Multivariate Analysis; Odds Ratio; Prospective Studies; Risk Factors; Single-Blind Method; Time Factors; Treatment Outcome; Urea | 2014 |
Urgent management of rapid heart rate in patients with atrial fibrillation/flutter and left ventricular dysfunction: comparison of the ultra-short-acting β1-selective blocker landiolol with digoxin (J-Land Study).
Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Flutter; Digoxin; Female; Heart Rate; Humans; Male; Middle Aged; Morpholines; Prospective Studies; Tachycardia; Urea; Ventricular Dysfunction, Left | 2013 |
A randomized, double-blind, placebo-controlled, phase II dose-finding study of the short acting β1-blocker, landiolol hydrochloride, in patients with suspected ischemic cardiac disease.
Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Chi-Square Distribution; Coronary Angiography; Double-Blind Method; Electrocardiography; Female; Heart Rate; Humans; Injections, Intravenous; Japan; Male; Middle Aged; Morpholines; Multidetector Computed Tomography; Myocardial Ischemia; Predictive Value of Tests; Time Factors; Urea | 2013 |
The effectiveness and safety of landiolol hydrochloride, an ultra-short-acting β1-blocker, in postoperative patients with supraventricular tachyarrhythmias: a multicenter, randomized, double-blind, placebo-controlled study.
Topics: Adrenergic beta-Antagonists; Aged; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heart Rate; Humans; Infusions, Intravenous; Male; Middle Aged; Morpholines; Postoperative Complications; Prospective Studies; Tachycardia, Supraventricular; Treatment Outcome; Urea | 2013 |
Pharmacokinetics, pharmacodynamics, and safety of landiolol hydrochloride in healthy Chinese subjects.
Topics: Adrenergic beta-Antagonists; Adult; Asian People; Blood Pressure; Chromatography, Liquid; Dose-Response Relationship, Drug; Electrocardiography; Female; Heart Rate; Humans; Male; Morpholines; Tandem Mass Spectrometry; Urea; Young Adult | 2014 |
Dose-finding study of landiolol hydrochloride: a short-acting β1-blocker for controlling heart rate during coronary computed-tomography angiography in Japan.
Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Artifacts; Blood Pressure; Coronary Angiography; Dose-Response Relationship, Drug; Female; Heart Rate; Humans; Japan; Male; Middle Aged; Morpholines; Multidetector Computed Tomography; Myocardial Ischemia; Urea | 2013 |
A randomized, double-blind, placebo-controlled, phase III study of the short-acting β1-adrenergic receptor blocker landiolol hydrochloride for coronary computed tomography angiography in Japanese patients with suspected ischemic cardiac disease.
Topics: Administration, Intravenous; Adrenergic beta-Antagonists; Aged; Blood Pressure; Coronary Angiography; Coronary Stenosis; Double-Blind Method; Female; Heart Rate; Humans; Image Enhancement; Male; Middle Aged; Morpholines; Tomography, X-Ray Computed; Urea | 2014 |
Perioperative use of a beta blocker in coronary artery bypass grafting.
Topics: Adrenergic beta-Antagonists; Aged; Anti-Arrhythmia Agents; Anti-Inflammatory Agents; Atrial Fibrillation; Biomarkers; C-Reactive Protein; Coronary Artery Bypass; Creatine Kinase, MB Form; Disease-Free Survival; Drug Administration Schedule; Humans; Incidence; Inflammation; Infusions, Parenteral; Japan; Male; Middle Aged; Morpholines; Prospective Studies; Time Factors; Treatment Outcome; Troponin I; Urea | 2013 |
Impacts of patient characteristics on the effectiveness of landiolol in AF/AFL patients complicated with LV dysfunction: Subgroup analysis of the J-Land study.
Topics: Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Digoxin; Drug Monitoring; Female; Heart Rate; Humans; Male; Middle Aged; Morpholines; Severity of Illness Index; Stroke Volume; Treatment Outcome; Urea; Ventricular Dysfunction, Left | 2014 |
A multicenter, open-label study of an intravenous short-acting β1-adrenergic receptor antagonist landiolol hydrochloride for coronary computed tomography angiography by 16-slice multi-detector computed tomography in Japanese patients with suspected ischem
Topics: Adrenergic beta-Antagonists; Aged; Coronary Angiography; Female; Heart Rate; Humans; Injections, Intravenous; Male; Middle Aged; Morpholines; Multidetector Computed Tomography; Myocardial Ischemia; Urea | 2014 |
Continuous administration of landiolol reduced QT dispersion in postoperative patients.
Topics: Adrenergic beta-Antagonists; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Pressure; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Electrocardiography; Female; Heart Rate; Humans; Infusions, Intravenous; Male; Middle Aged; Morpholines; Postoperative Care; Postoperative Complications; Prospective Studies; Urea | 2014 |
Landiolol in the treatment of the intraoperative supraventricular tachycardia: a multicenter, randomized, double-blind, placebo-controlled study.
Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Aged; Anti-Arrhythmia Agents; Blood Pressure; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypotension; Infusions, Intravenous; Intraoperative Complications; Male; Middle Aged; Morpholines; Propanolamines; Tachycardia, Supraventricular; Treatment Outcome; Urea; Young Adult | 2015 |
Safety and efficacy of landiolol hydrochloride for prevention of atrial fibrillation after cardiac surgery in patients with left ventricular dysfunction: Prevention of Atrial Fibrillation After Cardiac Surgery With Landiolol Hydrochloride for Left Ventric
Topics: Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Surgical Procedures; Female; Humans; Male; Morpholines; Postoperative Complications; Prospective Studies; Urea; Ventricular Dysfunction, Left | 2015 |
Pharmacokinetics and pharmacodynamics of two different landiolol formulations in a healthy Caucasian group.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Blood Pressure; Cross-Over Studies; Double-Blind Method; Drug Compounding; Female; Healthy Volunteers; Heart Rate; Humans; Male; Morpholines; Urea; White People; Young Adult | 2016 |
Landiolol infusion during general anesthesia does not prevent postoperative atrial fibrillation in patients undergoing lung resection.
Topics: Adrenergic beta-Antagonists; Aged; Anesthesia, General; Atrial Fibrillation; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Incidence; Infusions, Intravenous; Kaplan-Meier Estimate; Male; Middle Aged; Morpholines; Pneumonectomy; Postoperative Complications; Survival Rate; Urea | 2016 |
Study design for control of HEART rate in inFant and child tachyarrhythmia with heart failure Using Landiolol (HEARTFUL): A prospective, multicenter, uncontrolled clinical trial.
Topics: Adolescent; Adrenergic beta-Antagonists; Atrial Fibrillation; Atrial Flutter; Child; Child, Preschool; Female; Heart Failure; Heart Rate; Humans; Infant; Infusions, Intravenous; Male; Morpholines; Research Design; Tachycardia; Urea | 2017 |
Bolus application of landiolol and esmolol: comparison of the pharmacokinetic and pharmacodynamic profiles in a healthy Caucasian group.
Topics: Adrenergic beta-Antagonists; Adult; Double-Blind Method; Female; Humans; Male; Morpholines; Propanolamines; Prospective Studies; Urea; White People; Young Adult | 2017 |
The suppressive effects of landiolol administration on the occurrence of postoperative atrial fibrillation and tachycardia, and plasma IL-6 elevation in patients undergoing esophageal surgery: A randomized controlled clinical trial.
Topics: Adrenergic beta-Antagonists; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Cytokines; Esophageal Neoplasms; Esophagectomy; Female; Humans; Incidence; Infusions, Intravenous; Interleukin-6; Length of Stay; Male; Middle Aged; Morpholines; Perioperative Care; Postoperative Complications; Prospective Studies; Tachycardia, Sinus; Urea | 2017 |
Pharmacodynamic and -kinetic Behavior of Low-, Intermediate-, and High-Dose Landiolol During Long-Term Infusion in Whites.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Adult; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Humans; Infusions, Intravenous; Male; Morpholines; Prospective Studies; Urea; White People | 2017 |
Randomized clinical trial of landiolol hydrochloride for the prevention of atrial fibrillation and postoperative complications after oesophagectomy for cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Carcinoma, Squamous Cell; Double-Blind Method; Esophageal Neoplasms; Esophagectomy; Female; Humans; Male; Middle Aged; Morpholines; Postoperative Complications; Treatment Outcome; Urea | 2017 |
Pharmacokinetics and Pharmacodynamics of Low-, Intermediate-, and High-Dose Landiolol and Esmolol During Long-Term Infusion in Healthy Whites.
Topics: Adolescent; Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Adult; Blood Pressure; Cross-Over Studies; Czech Republic; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Healthy Volunteers; Heart Rate; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Morpholines; Propanolamines; Prospective Studies; Therapeutic Equivalency; Urea; White People; Young Adult | 2018 |
Landiolol in patients with septic shock resident in an intensive care unit (LANDI-SEP): study protocol for a randomized controlled trial.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Blood Pressure; Clinical Trials, Phase IV as Topic; Europe; Heart Rate; Humans; Intensive Care Units; Morpholines; Multicenter Studies as Topic; Prospective Studies; Randomized Controlled Trials as Topic; Shock, Septic; Time Factors; Treatment Outcome; Urea; Vasoconstrictor Agents | 2018 |
Perioperative Administration of an Intravenous Beta-Blocker Landiolol Hydrochloride in Patients with Lung Cancer: A Japanese Retrospective Exploratory Clinical Study.
Topics: Administration, Intravenous; Adrenergic beta-Antagonists; Aged; Disease-Free Survival; Female; Humans; Lung Neoplasms; Male; Middle Aged; Morpholines; Perioperative Care; Retrospective Studies; Survival Rate; Urea | 2019 |
Efficacy and Safety of the Ultra-Short-Acting β1-Selective Blocker Landiolol in Patients With Recurrent Hemodynamically Unstable Ventricular Tachyarrhymias - Outcomes of J-Land II Study.
Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Asian People; Disease-Free Survival; Female; Humans; Japan; Male; Middle Aged; Morpholines; Survival Rate; Tachycardia, Ventricular; Time Factors; Urea | 2019 |
Open-Label Two-Dose Pilot Study of Landiolol for the Treatment of Atrial Fibrillation/Atrial Flutter in Caucasian Patients.
Topics: Aged; Aged, 80 and over; Atrial Fibrillation; Atrial Flutter; Humans; Middle Aged; Morpholines; Pilot Projects; Prospective Studies; Urea | 2019 |
Landiolol, an ultra-short acting beta-1 blocker, for preventing postoperative lung cancer recurrence: study protocol for a phase III, multicenter randomized trial with two parallel groups of patients.
Topics: Adrenergic beta-1 Receptor Antagonists; Chemotherapy, Adjuvant; Clinical Trials, Phase III as Topic; Humans; Japan; Lung Neoplasms; Morpholines; Multicenter Studies as Topic; Neoplasm Metastasis; Neoplasm Recurrence, Local; Pneumonectomy; Progression-Free Survival; Randomized Controlled Trials as Topic; Time Factors; Urea | 2019 |
Efficacy and safety of landiolol, an ultra-short-acting β1-selective antagonist, for treatment of sepsis-related tachyarrhythmia (J-Land 3S): a multicentre, open-label, randomised controlled trial.
Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Female; Humans; Male; Morpholines; Sepsis; Tachycardia; Treatment Outcome; Urea | 2020 |
Preventive effect of low-dose landiolol on postoperative atrial fibrillation study (PELTA study).
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Atrial Fibrillation; Cardiovascular Surgical Procedures; Dose-Response Relationship, Drug; Electrocardiography; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Morpholines; Postoperative Complications; Prospective Studies; Treatment Outcome; Urea | 2020 |
Randomized controlled trial of landiolol, a short-acting beta-1 adrenergic receptor blocker, illustrating changes in high-molecular weight adiponectin levels after elective percutaneous coronary intervention.
Topics: Adiponectin; Adrenergic beta-1 Receptor Antagonists; Aged; Aged, 80 and over; Angina, Stable; Biomarkers; Coronary Artery Disease; Female; Humans; Japan; Male; Middle Aged; Molecular Weight; Morpholines; Percutaneous Coronary Intervention; Prospective Studies; Time Factors; Treatment Outcome; Urea | 2020 |
Pharmacodynamic and pharmacokinetic behavior of landiolol during dobutamine challenge in healthy adults.
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Cardiotonic Agents; Cross-Over Studies; Dobutamine; Double-Blind Method; Female; Healthy Volunteers; Heart Rate; Humans; Infusions, Intravenous; Male; Morpholines; Prospective Studies; Urea; Young Adult | 2020 |
Study into the reversal of septic shock with landiolol (beta blockade): STRESS-L Study protocol for a randomised trial.
Topics: COVID-19; England; Humans; Morpholines; Randomized Controlled Trials as Topic; Shock, Septic; Treatment Outcome; Urea | 2021 |
Microcirculatory effects of landiolol: a double-blind, randomised, controlled study after cardiac surgery.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Double-Blind Method; Heart Rate; Humans; Microcirculation; Morpholines; Prospective Studies; Time Factors; Treatment Outcome; Urea | 2021 |
Efficacy and Safety of Early Intravenous Landiolol on Myocardial Salvage in Patients with ST-segment Elevation Myocardial Infarction before Primary Percutaneous Coronary Intervention: A Randomized Study.
Topics: Administration, Intravenous; Adrenergic beta-Antagonists; Aged; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Morpholines; Myocardial Reperfusion Injury; Percutaneous Coronary Intervention; Prospective Studies; ST Elevation Myocardial Infarction; Urea | 2021 |
Blood Pressure Recovery After Dobutamine Antagonism: Partial With Landiolol, None With Esmolol.
Topics: Blood Pressure; Cross-Over Studies; Dobutamine; Humans; Morpholines; Propanolamines; Prospective Studies; Urea | 2022 |
Effects of Landiolol on Macrocirculatory Parameters and Left and Right Ventricular Performances Following Cardiac Surgery: A Randomized Controlled Trial.
Topics: Adrenergic beta-Antagonists; Atrial Fibrillation; Cardiac Surgical Procedures; Humans; Morpholines; Postoperative Complications; Prospective Studies; Urea | 2022 |
197 other study(ies) available for urea and landiolol
| Article | Year |
|---|---|
Development of a highly cardioselective ultra short-acting beta-blocker, ONO-1101.
Topics: Adrenergic beta-Antagonists; Animals; Dogs; Guinea Pigs; Heart Atria; Heart Rate; In Vitro Techniques; Morpholines; Structure-Activity Relationship; Tachycardia; Trachea; Urea | 1992 |
Effects of ONO-1101, a novel beta-antagonist, on action potential and membrane currents in cardiac muscle.
Topics: Action Potentials; Adrenergic beta-Antagonists; Animals; Dose-Response Relationship, Drug; Guinea Pigs; Heart; Male; Membrane Potentials; Morpholines; Propanolamines; Urea | 1996 |
[Toxicity studies of landiolol hydrochloride (ONO-1101) (1). Single intravenous toxicity study in rats and dogs].
Topics: Adrenergic beta-Antagonists; Animals; Body Weight; Dogs; Dose-Response Relationship, Drug; Eating; Female; Injections, Intravenous; Lethal Dose 50; Male; Morpholines; Motor Activity; Organ Size; Rats; Rats, Sprague-Dawley; Respiration; Urea | 1997 |
[Toxicity studies of landiolol hydrochloride (ONO-1101) (2). 4-week repeated dose intravenous toxicity study in rats with 4-week recovery test].
Topics: Adrenergic beta-Antagonists; Animals; Blood; Body Weight; Dose-Response Relationship, Drug; Eating; Eye; Female; Injections, Intravenous; Male; Morpholines; Organ Size; Rats; Rats, Sprague-Dawley; Reflex; Respiration; Time Factors; Urea; Urine | 1997 |
[Toxicity studies of landiolol hydrochloride (ONO-1101) (3). 4-week repeated dose intravenous toxicity study in dogs with 4-week recovery test].
Topics: Adrenergic beta-Antagonists; Animals; Blood; Body Temperature; Body Weight; Dogs; Dose-Response Relationship, Drug; Eating; Feces; Female; Injections, Intravenous; Kidney; Liver; Male; Morpholines; Organ Size; Rectum; Time Factors; Urea; Urine | 1997 |
[Reproductive and developmental toxicity studies of landiolol hydrochloride (ONO-1101) (1). Fertility study in rats].
Topics: Adrenergic beta-Antagonists; Animals; Body Weight; Dose-Response Relationship, Drug; Eating; Embryonic and Fetal Development; Female; Fertility; Fetus; Maternal-Fetal Exchange; Morpholines; Organ Size; Pregnancy; Rats; Rats, Sprague-Dawley; Urea | 1997 |
[Reproductive and developmental toxicity studies of landiolol hydrochloride (ONO-1101) (2). Teratogenicity study in rats].
Topics: Adrenergic beta-Antagonists; Animals; Body Weight; Dose-Response Relationship, Drug; Eating; Embryonic and Fetal Development; Female; Fetal Organ Maturity; Fetus; Injections, Intravenous; Male; Maternal-Fetal Exchange; Morpholines; Organ Size; Pregnancy; Pregnancy, Animal; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Reproduction; Urea | 1997 |
[Reproductive and developmental toxicity studies of landiolol hydrochloride (ONO-1101) (3). Teratogenicity study in rabbits].
Topics: Adrenergic beta-Antagonists; Animals; Body Weight; Dose-Response Relationship, Drug; Eating; Embryonic and Fetal Development; Female; Fetus; Injections, Intravenous; Maternal-Fetal Exchange; Morpholines; Organ Size; Pregnancy; Pregnancy, Animal; Rabbits; Urea | 1997 |
[Reproductive and developmental toxicity studies of landiolol hydrochloride (ONO-1101) (4). Perinatal and postnatal study in rats].
Topics: Adrenergic beta-Antagonists; Animals; Body Weight; Eating; Female; Fertility; Injections, Intravenous; Lactation; Male; Maternal-Fetal Exchange; Morpholines; Organ Size; Pregnancy; Pregnancy, Animal; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Urea | 1997 |
Time course of a new ultrashort-acting beta-adrenoceptor-blocking drug, ONO-1101: comparison with those of esmolol and propranolol by using the canine isolated, blood-perfused heart preparations.
Topics: Adrenergic beta-Antagonists; Animals; Blood; Dogs; Female; Heart; Hemodynamics; In Vitro Techniques; Male; Morpholines; Myocardial Contraction; Perfusion; Propanolamines; Propranolol; Sinoatrial Node; Urea | 1998 |
The effects of a new ultra-short-acting beta-adrenergic blocker, ONO-1101, on cardiac function during and after cardiopulmonary bypass.
Topics: Adrenergic beta-Antagonists; Animals; Cardiopulmonary Bypass; Dogs; Electrocardiography; Heart; Hemodynamics; Morpholines; Urea | 1999 |
Landiolol decreases a dysrhythmogenic dose of epinephrine in dogs during halothane anesthesia.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Anesthetics, Inhalation; Animals; Anti-Arrhythmia Agents; Dogs; Drug Interactions; Epinephrine; Female; Halothane; Male; Morpholines; Time Factors; Urea; Ventricular Premature Complexes | 1999 |
Electrophysiologic, cardiohemodynamic and beta-blocking actions of a new ultra-short-acting beta-blocker, ONO-1101, assessed by the in vivo canine model in comparison with esmolol.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Anesthesia; Animals; Anti-Arrhythmia Agents; Dogs; Dose-Response Relationship, Drug; Drug Interactions; Electric Stimulation; Electrocardiography; Female; Hemodynamics; Isoproterenol; Male; Morpholines; Propanolamines; Time Factors; Urea | 1999 |
Landiolol. ONO 1011.
Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drugs, Investigational; Guinea Pigs; Humans; In Vitro Techniques; Morpholines; Urea | 1999 |
Modifications of the hemodynamic consequences of theophylline intoxication with landiolol in halothane-anesthetized dogs.
Topics: Adrenergic Agonists; Adrenergic beta-Antagonists; Aminophylline; Analysis of Variance; Anesthetics, Inhalation; Animals; Anti-Arrhythmia Agents; Blood Pressure; Cardiac Output; Disease Models, Animal; Dogs; Epinephrine; Female; Halothane; Heart Rate; Hemodynamics; Male; Morpholines; Norepinephrine; Pulmonary Artery; Pulmonary Wedge Pressure; Random Allocation; Tachycardia; Theophylline; Urea; Vascular Resistance; Vasodilator Agents | 2000 |
Salutary antiarrhythmic effect of combining a K channel blocker and a beta-blocker in a canine model of 7-day-old myocardial infarction.
Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disease Models, Animal; Dogs; Drug Therapy, Combination; Electrocardiography; Female; Heart; Heart Ventricles; Male; Morpholines; Myocardial Infarction; Piperidines; Potassium Channel Blockers; Pyridines; Urea | 2000 |
Ultra-short-acting cardioselective beta-blockade attenuates postischemic cardiac dysfunction in the isolated rat heart.
Topics: Adrenergic beta-Antagonists; Animals; Bicarbonates; Calcium Chloride; Heart; Heart Arrest, Induced; In Vitro Techniques; Ischemic Preconditioning, Myocardial; Magnesium; Male; Morpholines; Potassium Chloride; Rats; Rats, Wistar; Sodium Chloride; Urea | 2001 |
In rabbits, landiolol, a new ultra-short-acting beta-blocker, exerts a more potent negative chronotropic effect and less effect on blood pressure than esmolol.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Depression, Chemical; Dose-Response Relationship, Drug; Heart Rate; Male; Morpholines; Propanolamines; Rabbits; Urea | 2001 |
Landiolol, esmolol and propranolol protect from ischemia/reperfusion injury in isolated guinea pig hearts.
Topics: Adrenergic beta-Antagonists; Animals; Guinea Pigs; Heart; In Vitro Techniques; Male; Morpholines; Myocardial Reperfusion Injury; Propanolamines; Propranolol; Time Factors; Urea; Ventricular Function, Left | 2003 |
[Successful control of rapid heart rate in a patient with atrial fibrillation by continuous intravenous administration of landiolol hydrochloride].
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Humans; Infusions, Intravenous; Male; Morpholines; Tachycardia; Urea | 2003 |
Managing a tachyarrhythmia in a patient with pheochromocytoma with landiolol, a novel ultrashort-acting beta-adrenergic blocker.
Topics: Adrenal Gland Neoplasms; Adrenergic beta-Antagonists; Anesthesia; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrocardiography; Female; Humans; Intraoperative Complications; Middle Aged; Morpholines; Pheochromocytoma; Urea | 2003 |
Milrinone attenuates the negative inotropic effects of landiolol in halothane-anesthetized dogs.
Topics: Adrenergic beta-Antagonists; Anesthesia, Inhalation; Anesthetics, Inhalation; Animals; Cardiotonic Agents; Dogs; Halothane; Heart Rate; Milrinone; Morpholines; Myocardial Contraction; Urea | 2003 |
The efficacy of bolus administration of landiolol for attenuating tachycardia in pheochromocytoma.
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Aged; Aged, 80 and over; Anesthesia, General; Anti-Arrhythmia Agents; Electroencephalography; Epinephrine; Humans; Male; Morpholines; Pheochromocytoma; Tachycardia; Urea | 2004 |
[Successful treatment for tachyarrhythmia with ultra short acting beta-blocker during beating coronary artery bypass grafting; report of a case].
Topics: Adrenergic beta-Antagonists; Coronary Artery Bypass; Humans; Infusions, Intravenous; Intraoperative Complications; Male; Middle Aged; Morpholines; Tachycardia; Treatment Outcome; Urea | 2004 |
[Short-acting beta 1-adrenergic blocker is useful for anesthetic management of cesarean section in a patient with Marfan syndrome].
Topics: Adrenergic beta-Antagonists; Adult; Anesthesia, Obstetrical; Anesthesia, Spinal; Aorta; Cesarean Section; Dilatation, Pathologic; Female; Hemodynamics; Humans; Infusions, Intravenous; Intraoperative Care; Marfan Syndrome; Monitoring, Intraoperative; Morpholines; Pregnancy; Pregnancy Complications; Treatment Outcome; Urea | 2004 |
[Clinical experience of landiolol for the treatment of intraoperative rapid atrial fibrillation].
Topics: Adrenergic beta-Antagonists; Aged; Atrial Fibrillation; Cardiopulmonary Bypass; Cardiovascular Surgical Procedures; Female; Humans; Intraoperative Complications; Morpholines; Reoperation; Treatment Outcome; Urea | 2004 |
[Perioperative heart rate control with landiolol for a patient with rapid atrial fibrillation complicated with low cardiac function].
Topics: Anesthesia, Epidural; Anesthesia, General; Anti-Arrhythmia Agents; Atrial Fibrillation; Electrocardiography; Heart; Heart Rate; Humans; Lung Neoplasms; Male; Middle Aged; Morpholines; Pancreatic Neoplasms; Urea | 2004 |
[The successful anesthetic management of a patient with pheochromocytoma using prostaglandin E1 and a novel, short-acting beta-adrenergic blocker: landiolol hydrochloride].
Topics: Adrenal Gland Neoplasms; Adrenergic beta-Antagonists; Alprostadil; Anesthesia, Epidural; Anesthesia, General; Antihypertensive Agents; Humans; Intraoperative Care; Male; Middle Aged; Morpholines; Pheochromocytoma; Urea; Vasodilator Agents | 2004 |
Conversion of atrial fibrillation to sinus rhythm during landiolol infusion.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Female; Humans; Infusions, Intravenous; Intracranial Aneurysm; Intraoperative Care; Morpholines; Urea | 2004 |
Successful management of tachycardiac atrial fibrillation in a septic patient with landiolol.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Hemodynamics; Humans; Intraoperative Complications; Laparoscopy; Male; Morpholines; Peritonitis; Sepsis; Tachycardia; Urea | 2005 |
[Effects of landiolol hydrochloride on cardiohemodynamics in patients who underwent coronary artery bypass grafting].
Topics: Adrenergic beta-Antagonists; Aged; Blood Pressure; Central Venous Pressure; Coronary Artery Bypass; Depression, Chemical; Female; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Morpholines; Urea; Vascular Resistance | 2005 |
Successful management of cesarean section in a patient with Romano-Ward syndrome using landiolol, a selective and short-acting beta1 receptor antagonist.
Topics: Adrenergic beta-Antagonists; Adult; Cesarean Section; Electrocardiography; Female; Humans; Morpholines; Pregnancy; Pregnancy Complications, Cardiovascular; Romano-Ward Syndrome; Urea | 2005 |
[Landiolol does not affect bispectral index scale in off-pump coronary artery bypass surgery in patients under fast-track cardiac anesthesia].
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Coronary Artery Bypass, Off-Pump; Female; Hemodynamics; Humans; Male; Middle Aged; Morpholines; Urea | 2005 |
[Successful weaning from cardiopulmonary bypass with administration of landiolol hydrochloride in a patient with hypertrophic obstructive cardiomyopathy].
Topics: Adolescent; Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Cardiomyopathy, Hypertrophic; Cardiopulmonary Bypass; Catheter Ablation; Humans; Intra-Aortic Balloon Pumping; Male; Morpholines; Urea | 2005 |
Effect of landiolol on nonsustained ventricular tachycardia during electroconvulsive therapy.
Topics: Adrenergic beta-Antagonists; Adult; Anti-Arrhythmia Agents; Electroconvulsive Therapy; Humans; Male; Morpholines; Tachycardia, Ventricular; Urea | 2005 |
Effectiveness of bolus landiolol on paroxysmal atrial tachycardia.
Topics: Aged, 80 and over; Anesthesia, Spinal; Anti-Arrhythmia Agents; Bundle-Branch Block; Electrocardiography; Humans; Intraoperative Complications; Male; Morpholines; Tachycardia, Paroxysmal; Urea | 2005 |
Landiolol and peri-induction tachycardia.
Topics: Adrenergic beta-Antagonists; Heart Rate; Humans; Intubation, Intratracheal; Morpholines; Tachycardia; Urea | 2006 |
[Case in which landiolol hydrochloride improved left ventricular outflow tract obstruction with systolic anterior motion of the mitral valve following mitral valve plasty].
Topics: Adrenergic beta-Antagonists; Aged; Heart Valve Prosthesis Implantation; Humans; Male; Mitral Valve; Mitral Valve Insufficiency; Morpholines; Postoperative Complications; Shock; Systole; Treatment Outcome; Urea; Ventricular Outflow Obstruction | 2006 |
[Effects of continuous infusion of landiolol on the hemodynamic response to tracheal intubation].
Topics: Adrenergic beta-Antagonists; Blood Pressure; Buprenorphine; Heart Rate; Hemodynamics; Humans; Intubation, Intratracheal; Lidocaine; Morpholines; Urea | 2006 |
Landiolol, an ultra-short-acting beta 1-adrenoceptor antagonist, does not alter the electroencephalographic effect of isoflurane in swine model.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Anesthetics, Inhalation; Animals; Dose-Response Relationship, Drug; Drug Interactions; Electroencephalography; Hemodynamics; Isoflurane; Models, Animal; Morpholines; Swine; Urea | 2006 |
Landiolol enhances effect of ischemic preconditioning in isolated rabbit hearts.
Topics: Adrenergic beta-Antagonists; Animals; Cardiotonic Agents; Heart; Ischemic Preconditioning, Myocardial; Male; Morpholines; Myocardial Reperfusion Injury; Rabbits; Urea; Ventricular Function, Left | 2006 |
Use of landiolol in the perioperative management of supraventricular tachycardia.
Topics: Anti-Arrhythmia Agents; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Cardiotonic Agents; Dopamine; Ebstein Anomaly; Electric Countershock; Female; Heart Rate; Humans; Hypotension; Middle Aged; Morpholines; Perioperative Care; Postoperative Complications; Tachycardia, Supraventricular; Treatment Outcome; Urea | 2006 |
Beta-adrenoreceptor antagonists attenuate brain injury after transient focal ischemia in rats.
Topics: Adrenergic beta-Antagonists; Anesthesia; Anesthetics, Inhalation; Animals; Brain; Carbazoles; Carvedilol; Halothane; Ischemic Attack, Transient; Male; Morpholines; Myocardial Infarction; Propanolamines; Propranolol; Rats; Rats, Sprague-Dawley; Tetrazolium Salts; Urea | 2006 |
[Effect of landiolol on heart rate control of atrial fibrillation in a patient with sick sinus syndrome under ventricular pacing].
Topics: Anesthesia, General; Anti-Asthmatic Agents; Arthroplasty, Replacement; Atrial Fibrillation; Cardiac Pacing, Artificial; Heart Rate; Heart Ventricles; Humans; Infusions, Intravenous; Intraoperative Care; Intraoperative Complications; Male; Middle Aged; Morpholines; Shoulder Joint; Sick Sinus Syndrome; Treatment Outcome; Urea | 2006 |
[The effects of continuous infusion of landiolol on heart rate changes after neostigmine-atropine administration during recovery from general anesthesia].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Anesthesia Recovery Period; Anesthesia, General; Atropine; Female; Heart Rate; Humans; Infusions, Intravenous; Male; Middle Aged; Morpholines; Neostigmine; Urea | 2006 |
Age and sex-related differences in dose-dependent hemodynamic response to landiolol hydrochloride during general anesthesia.
Topics: Adrenergic beta-Antagonists; Adult; Age Factors; Aged; Blood Pressure; Dose-Response Relationship, Drug; Double-Blind Method; Female; Half-Life; Heart Rate; Humans; Logistic Models; Male; Middle Aged; Morpholines; Sex Characteristics; Urea | 2007 |
[Successful anesthetic management of a patient with thyroid storm using landiolol].
Topics: Adrenergic beta-Antagonists; Adult; Anesthesia, Inhalation; Humans; Infusions, Intravenous; Male; Methimazole; Morpholines; Peptic Ulcer Perforation; Perioperative Care; Stomach Ulcer; Thyroid Crisis; Treatment Outcome; Urea | 2007 |
Intrathecal landiolol inhibits nociception and spinal c-Fos expression in the mouse formalin test.
Topics: Adrenergic beta-Antagonists; Anesthesia, Spinal; Animals; Formaldehyde; Injections, Spinal; Male; Mice; Morpholines; Pain; Pain Measurement; Posterior Horn Cells; Proto-Oncogene Proteins c-fos; Random Allocation; Spinal Cord; Statistics, Nonparametric; Urea | 2007 |
[Landiolol prevented myocardial ischemia in a patient with severe aortic stenosis undergoing total gastrectomy].
Topics: Adrenergic beta-Antagonists; Aged; Aortic Valve Stenosis; Gastrectomy; Humans; Male; Morpholines; Myocardial Ischemia; Stomach Neoplasms; Urea | 2007 |
Landiolol has cardioprotective effects against reperfusion injury in the rat heart via the PKCepsilon signaling pathway.
Topics: Adrenergic beta-Antagonists; Alkaloids; Animals; Benzophenanthridines; Cardiotonic Agents; Glyburide; Heart; Ischemic Preconditioning; Male; Morpholines; Myocardial Ischemia; Phosphorylation; Protein Kinase C-epsilon; Rats; Rats, Wistar; Reperfusion Injury; Signal Transduction; Urea | 2007 |
Landiolol, an ultra short-acting beta1-adrenoceptor antagonist, does not alter the minimum alveolar anesthetic concentration of isoflurane in a swine model.
Topics: Administration, Inhalation; Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Anesthetics, Inhalation; Animals; Blood Pressure; Cardiac Output; Consciousness; Dose-Response Relationship, Drug; Heart Rate; Isoflurane; Models, Animal; Morpholines; Pain Measurement; Pain Threshold; Pulmonary Alveoli; Receptors, Adrenergic, beta-1; Swine; Urea | 2007 |
Pre-ischemic administration of landiolol prevents ischemia-reperfusion injury in the rat heart.
Topics: Adrenergic beta-Antagonists; Animals; Dose-Response Relationship, Drug; Heart; Ischemic Preconditioning, Myocardial; Male; Morpholines; Myocardial Reperfusion Injury; Myocardium; Rats; Rats, Wistar; Reperfusion Injury; Urea; Ventricular Dysfunction, Left | 2007 |
Incessant non-sustained ventricular tachycardia after stimulus of electroconvulsive therapy with atropine premedication?
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Atropine; Depressive Disorder, Major; Electrocardiography; Electroconvulsive Therapy; Humans; Infusions, Intravenous; Male; Middle Aged; Morpholines; Preanesthetic Medication; Recurrence; Retreatment; Tachycardia, Ventricular; Urea; Ventricular Premature Complexes | 2007 |
Cardioprotective effect and mechanism of action of landiolol on the ischemic reperfused heart.
Topics: Adrenergic beta-Antagonists; Animals; Calcium; Calcium-Binding Proteins; Cardiotonic Agents; Guinea Pigs; Heart Rate; Ischemic Preconditioning, Myocardial; Lipid Peroxidation; Male; Morpholines; Myocardial Reperfusion Injury; Phosphorylation; Reactive Oxygen Species; Urea; Ventricular Function, Left | 2007 |
[Anesthetic management for on-pump coronary arterial bypass graft in a patient with cardiac resynchronization therapy].
Topics: Aged; Anesthesia; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Coronary Artery Bypass; Humans; Male; Morpholines; Perioperative Care; Tachycardia; Treatment Outcome; Urea | 2008 |
High concentrations of landiolol, a beta(1)-adrenoceptor antagonist, stimulate smooth muscle contraction of the rat trachea through the Rho-kinase pathway.
Topics: Adrenergic beta-Antagonists; Animals; Dose-Response Relationship, Drug; Male; Morpholines; Muscle Contraction; Muscle, Smooth; Rats; Rats, Wistar; rho-Associated Kinases; Signal Transduction; Trachea; Treatment Outcome; Urea | 2008 |
Clinical role and efficacy of landiolol in the intensive care unit.
Topics: Adrenergic beta-Antagonists; Aged; Atrial Fibrillation; Blood Pressure; Catecholamines; Female; Heart Rate; Humans; Intensive Care Units; Male; Middle Aged; Morpholines; Myocardial Ischemia; Retrospective Studies; Time Factors; Treatment Outcome; Urea | 2008 |
Low-dose landiolol for hypertension with tachycardia following neurosurgery.
Topics: Adrenergic beta-Antagonists; Aged; Dose-Response Relationship, Drug; Female; Humans; Hypertension; Male; Middle Aged; Morpholines; Neurosurgical Procedures; Tachycardia; Treatment Outcome; Urea | 2008 |
Use of landiolol for treatment of atrial fibrillation in a patient with terminal cancer.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Colonic Neoplasms; Female; Humans; Morpholines; Tachycardia; Terminal Care; Urea | 2010 |
A short-acting beta-blocker, landiolol, attenuates systolic anterior motion of the mitral valve after mitral valve annuloplasty.
Topics: Adrenergic beta-Antagonists; Aged; Female; Hemodynamics; Humans; Male; Middle Aged; Mitral Valve; Mitral Valve Insufficiency; Morpholines; Systole; Treatment Outcome; Urea | 2008 |
[Use of landiolol hydrochloride for the prevention of atrial fibrillation after lung resection].
Topics: Adrenergic beta-Antagonists; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Female; Humans; Male; Middle Aged; Morpholines; Pneumonectomy; Postoperative Complications; Urea | 2008 |
Successful treatment with landiolol for the recurrence of significant ST-segment depression during early postoperative period.
Topics: Anti-Arrhythmia Agents; Endarterectomy, Carotid; Humans; Male; Middle Aged; Morpholines; Myocardial Ischemia; Postoperative Complications; Tachycardia; Urea | 2008 |
Landiolol, an ultrashort-acting beta1-adrenoceptor antagonist, has protective effects in an LPS-induced systemic inflammation model.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Blotting, Western; Disease Models, Animal; Heart Rate; Hemodynamics; HMGB1 Protein; Immunohistochemistry; Inflammation; Interleukin-6; Lipopolysaccharides; Lung; Male; Morpholines; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha; Urea | 2009 |
[Perioperative and postoperative management of two patients with uncontrolled hyperthyroidism using short acting beta blocker, landiolol].
Topics: Adrenergic beta-Antagonists; Adult; Anesthesia; Antithyroid Agents; Fracture Fixation, Internal; Humans; Hypertension; Hyperthyroidism; Intraoperative Complications; Male; Mandibular Fractures; Morpholines; Perioperative Care; Pneumothorax; Postoperative Complications; Tachycardia; Thoracic Surgery, Video-Assisted; Thyroid Crisis; Urea | 2008 |
Landiolol has a less potent negative inotropic effect than esmolol in isolated rabbit hearts.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Dose-Response Relationship, Drug; Female; Heart Rate; In Vitro Techniques; Isoproterenol; Male; Morpholines; Myocardial Contraction; Myocardium; Oxygen Consumption; Propanolamines; Rabbits; Urea; Ventricular Function, Left | 2008 |
[Clinical evaluation of landiolol hydrochloride, an ultra short-acting beta-blocker].
Topics: Adrenergic beta-Antagonists; Aged; Anti-Arrhythmia Agents; Double-Blind Method; Female; Humans; Male; Middle Aged; Morpholines; Tachycardia, Supraventricular; Urea | 2008 |
[Postoperative management using ultra-short-acting beta-blocker (landiolol) in patients with aortic stenosis after aortic valve replacement].
Topics: Adrenergic beta-Antagonists; Aged; Aortic Valve; Aortic Valve Stenosis; Female; Heart Valve Prosthesis; Humans; Morpholines; Postoperative Care; Urea | 2008 |
Validation of HPLC-UV methods for quantitatively determining landiolol and its major metabolite in human blood.
Topics: Blood Chemical Analysis; Chromatography, High Pressure Liquid; Humans; Morpholines; Quality Control; Spectrophotometry, Ultraviolet; Urea | 2009 |
Comparative effects of ultra-short-acting beta1-blockers on voltage-gated tetrodotoxin-resistant Na+ channels in rat sensory neurons.
Topics: Adrenergic beta-Antagonists; Animals; Drug Resistance; Electrophysiological Phenomena; Ion Channel Gating; Kinetics; Male; Morpholines; Patch-Clamp Techniques; Propanolamines; Rats; Rats, Sprague-Dawley; Sensory Receptor Cells; Sodium Channels; Tetrodotoxin; Time Factors; Urea | 2009 |
Effect of low-dose landiolol, an ultrashort-acting beta-blocker, on postoperative atrial fibrillation after CABG surgery.
Topics: Adrenergic beta-Antagonists; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiopulmonary Bypass; Coronary Artery Bypass; Drug Administration Schedule; Female; Half-Life; Humans; Male; Middle Aged; Morpholines; Retrospective Studies; Treatment Outcome; Urea | 2009 |
Detection of landiolol using high-performance liquid chromatography/fluorescence: a blood esterase-sensitive ultra-short-acting beta(1)-receptor antagonist.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Adult; Aged; Chromatography, High Pressure Liquid; Esterases; Half-Life; Humans; Middle Aged; Morpholines; Spectrometry, Fluorescence; Urea | 2009 |
[General anesthesia for cesarean section in a patient with moyamoya disease].
Topics: Adult; Anesthesia, General; Anesthesia, Obstetrical; Anti-Arrhythmia Agents; Cesarean Section; Emergencies; Female; Humans; Hypertension; Intraoperative Complications; Morpholines; Moyamoya Disease; Perioperative Care; Pregnancy; Pregnancy Complications; Tachycardia; Urea | 2009 |
Postoperative administration of landiolol hydrochloride for patients with supraventricular arrhythmia: the efficacy of sustained intravenous infusion at a low dose.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Atrial Premature Complexes; Blood Pressure; Drug Administration Schedule; Female; Heart Rate; Humans; Infusions, Intravenous; Male; Middle Aged; Morpholines; Postoperative Care; Surgical Procedures, Operative; Tachycardia, Sinus; Time Factors; Treatment Outcome; Urea | 2009 |
Efficacy of intracoronary administration of a short-acting β-blocker landiolol during reperfusion in pigs.
Topics: Adrenergic beta-Antagonists; Animals; Coronary Vessels; Dose-Response Relationship, Drug; Injections, Intra-Arterial; Morpholines; Myocardial Infarction; Reperfusion Injury; Swine; Time Factors; Urea | 2011 |
Continuous hypertension and tachycardia after resection of a hemangioblastoma behind the dorsal medulla oblongata: relationship to sympathetic overactivity at the neurogenic vasomotor center.
Topics: Adrenergic beta-Antagonists; Autonomic Nervous System Diseases; Baroreflex; Brain Stem Neoplasms; Calcium Channel Blockers; Diltiazem; Hemangioblastoma; Humans; Hypertension; Magnetic Resonance Imaging; Male; Medulla Oblongata; Morpholines; Postoperative Complications; Solitary Nucleus; Tachycardia; Urea; Vasomotor System; Young Adult | 2010 |
Transient sinus arrest during continuous infusion of landiolol in an elderly patient.
Topics: Adrenergic beta-Antagonists; Aged, 80 and over; Anesthesia, General; Anti-Arrhythmia Agents; Female; Hemodynamics; Humans; Infusions, Intravenous; Monitoring, Intraoperative; Morpholines; Sinus Arrest, Cardiac; Skin Transplantation; Urea | 2009 |
Postoperative treatment of carvedilol following low dose landiolol has preventive effect for atrial fibrillation after coronary artery bypass grafting.
Topics: Adrenergic beta-Antagonists; Atrial Fibrillation; Carbazoles; Carvedilol; Coronary Artery Bypass; Female; Humans; Male; Middle Aged; Morpholines; Propanolamines; Retrospective Studies; Tachycardia; Treatment Outcome; Urea | 2009 |
Landiolol, an ultra short acting beta1-blocker, improves pulmonary edema after cardiopulmonary resuscitation with epinephrine in rats.
Topics: Acid-Base Equilibrium; Adrenergic alpha-Agonists; Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Body Weight; Carbon Dioxide; Cardiopulmonary Resuscitation; Drug Therapy, Combination; Epinephrine; Hematocrit; Lung; Male; Morpholines; Organ Size; Oxygen; Pulmonary Edema; Rats; Rats, Sprague-Dawley; Time Factors; Troponin I; Urea | 2010 |
Conversion of atrial flutter to sinus rhythm during landiolol infusion.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Hernia, Inguinal; Humans; Infusions, Intravenous; Intraoperative Complications; Laparoscopy; Morpholines; Treatment Outcome; Urea | 2010 |
[Case of thyroid crisis with persistent tachycardia diagnosed postoperatively].
Topics: Adult; Anti-Arrhythmia Agents; Emergencies; Fractures, Bone; Graves Disease; Humans; Intraoperative Complications; Iodine Compounds; Male; Morpholines; Orthopedic Procedures; Propylthiouracil; Tachycardia; Thyroid Crisis; Urea | 2009 |
Landiolol does not enhance the effect of ischemic preconditioning in isolated rat hearts.
Topics: Adrenergic beta-Antagonists; Animals; Dose-Response Relationship, Drug; Heart; Hemodynamics; Ischemic Preconditioning, Myocardial; Male; Morpholines; Myocardial Reperfusion Injury; Myocardium; Oxygen Consumption; Rats; Rats, Sprague-Dawley; Urea | 2010 |
Successful management of a patient with Marfan syndrome complicated with acute aortic dissection using landiolol during Cesarean section.
Topics: Adrenergic beta-Antagonists; Adult; Aortic Aneurysm; Aortic Dissection; Blood Pressure; Cesarean Section; Female; Heart Rate; Humans; Marfan Syndrome; Morpholines; Pregnancy; Pregnancy Complications, Cardiovascular; Tachycardia; Treatment Outcome; Urea; Uterine Contraction | 2010 |
Esmolol and landiolol, selective beta1-adrenoreceptor antagonists, provide neuroprotection against spinal cord ischemia and reperfusion in rats.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Blood Gas Analysis; Hemodynamics; Hindlimb; Male; Morpholines; Motor Activity; Motor Neurons; Movement Disorders; Neuroprotective Agents; Propanolamines; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Spinal Cord; Spinal Cord Ischemia; Urea | 2010 |
Safe use of landiolol hydrochloride in a patient with marked pseudocholinesterase deficiency.
Topics: Adrenergic beta-Antagonists; Aged, 80 and over; Anesthesia, General; Butyrylcholinesterase; Humans; Male; Morpholines; Treatment Outcome; Urea; Ventriculoperitoneal Shunt | 2010 |
[Effects of landiolol on hemodynamic improvement and prevention of atrial fibrillation in the perioperative period of off-pump coronary artery bypass grafting].
Topics: Adrenergic beta-Antagonists; Aged; Atrial Fibrillation; Coronary Artery Bypass, Off-Pump; Female; Hemodynamics; Humans; Male; Morpholines; Perioperative Care; Urea | 2010 |
[Clinical analysis of precaution against atrial fibrillation following cardiac surgery: landiolol or amiodarone?].
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Surgical Procedures; Female; Humans; Male; Morpholines; Postoperative Complications; Urea | 2010 |
[Landiolol hydrochloride is useful for anesthetic management of cesarean section in a patient with Basedow disease].
Topics: Adrenergic beta-Antagonists; Adult; Anesthesia, Epidural; Anesthesia, Obstetrical; Anesthesia, Spinal; Cesarean Section; Elective Surgical Procedures; Female; Graves Disease; Humans; Intraoperative Complications; Morpholines; Perioperative Care; Pregnancy; Pregnancy Complications; Tachycardia; Urea | 2010 |
Post-treatment with selective β1 adrenoceptor antagonists provides neuroprotection against transient focal ischemia in rats.
Topics: Adrenergic beta-Antagonists; Animals; Brain Infarction; Brain Ischemia; Disease Models, Animal; Male; Morpholines; Nerve Degeneration; Neuroprotective Agents; Propanolamines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta-1; Treatment Outcome; Urea | 2010 |
Metoclopramide does not prolong duration of action of landiolol attenuating the hemodynamic response to induction of anesthesia and tracheal intubation.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Anesthesia; Blood Pressure; Drug Interactions; Heart Rate; Hemodynamics; Humans; Intubation, Intratracheal; Metoclopramide; Middle Aged; Morpholines; Urea | 2010 |
Effective control of paroxysmal tachycardia with landiolol hydrochloride during cesarean section in a patient with hypertrophic obstructive cardiomyopathy.
Topics: Adult; Anti-Arrhythmia Agents; Cardiomyopathy, Hypertrophic; Cesarean Section; Elective Surgical Procedures; Female; Hemodynamics; Humans; Morpholines; Postoperative Complications; Pregnancy; Tachycardia, Paroxysmal; Urea | 2010 |
[Effect of intra-operative low-dose infusion of landiolol hydrochloride on post-operative atrial fibrillation after off-pump coronary artery bypass grafting].
Topics: Adrenergic beta-Antagonists; Aged; Atrial Fibrillation; Coronary Artery Bypass, Off-Pump; Female; Humans; Infusions, Intravenous; Intraoperative Period; Male; Morpholines; Postoperative Complications; Retrospective Studies; Urea | 2010 |
[Landiolol infusion attenuates increase in heart rate, but does not prevent increase in blood pressure in response to emergence from anesthesia and tracheal extubation].
Topics: Adrenergic beta-Antagonists; Anesthesia Recovery Period; Blood Pressure; Heart Rate; Humans; Intubation, Intratracheal; Middle Aged; Morpholines; Urea | 2010 |
Neuroprotective effects and suppression of ischemia-induced glutamate elevation by β1-adrenoreceptor antagonists administered before transient focal ischemia in rats.
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Behavior, Animal; Blood Gas Analysis; Body Temperature; Brain Chemistry; Consciousness Disorders; Extracellular Space; Gait Disorders, Neurologic; Glutamic Acid; Hemodynamics; Infarction, Middle Cerebral Artery; Ischemic Attack, Transient; Male; Microdialysis; Morpholines; Neuroprotective Agents; Norepinephrine; Pain Threshold; Propanolamines; Rats; Rats, Sprague-Dawley; Reflex; Urea | 2011 |
Adequacy of control of preoperative hypertension can affect landiolol-induced hemodynamic changes in elderly patients during emergence from anesthesia.
Topics: Adrenergic beta-Antagonists; Aged; Anesthesia; Blood Pressure; Dose-Response Relationship, Drug; Heart Rate; Humans; Hypertension; Morpholines; Preoperative Care; Urea | 2011 |
Effect of landiolol hydrochloride, an ultra-short-acting beta 1-selective blocker, on supraventricular tachycardia, atrial fibrillation and flutter after pulmonary resection.
Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Aged, 80 and over; Atrial Fibrillation; Atrial Flutter; Female; Heart Rate; Humans; Infusions, Intravenous; Lung Diseases; Male; Middle Aged; Morpholines; Retrospective Studies; Secondary Prevention; Tachycardia, Supraventricular; Treatment Outcome; Urea | 2012 |
Landiolol reduces coronary artery motion in an open-chest porcine model: implications for off-pump coronary artery bypass surgery.
Topics: Adrenergic beta-Antagonists; Animals; Coronary Artery Bypass, Off-Pump; Coronary Artery Disease; Coronary Vessels; Disease Models, Animal; Female; Imaging, Three-Dimensional; Infusions, Intravenous; Morpholines; Myocardial Contraction; Swine; Thoracotomy; Urea; Vasodilation | 2012 |
Efficacy of low-dose landiolol, an ultrashort-acting β-blocker, on postoperative atrial fibrillation in patients undergoing pulmonary resection for lung cancer.
Topics: Adrenergic beta-Antagonists; Aged; Atrial Fibrillation; Female; Hemodynamics; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Morpholines; Pneumonectomy; Postoperative Complications; Urea | 2011 |
Effect and safety of landiolol in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.
Topics: Angioplasty, Balloon, Coronary; Female; Humans; Male; Morpholines; Myocardial Infarction; Urea; Ventricular Remodeling | 2012 |
[Comparative study between landiolol and amiodarone for therapeutic efficacy after open heart surgery].
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiac Surgical Procedures; Female; Humans; Morpholines; Postoperative Complications; Tachycardia; Urea | 2011 |
Direct effects of esmolol and landiolol on cardiac function, coronary vasoactivity, and ventricular electrophysiology in guinea-pig hearts.
Topics: Action Potentials; Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Blood Pressure; Computer Simulation; Dose-Response Relationship, Drug; Guinea Pigs; Heart Rate; Morpholines; Myocytes, Cardiac; Propanolamines; Time Factors; Urea; Ventricular Function, Left | 2012 |
Intravenous infusion of ultra-short-acting β-blocker for postoperative atrial fibrillation is the one of choice.
Topics: Adrenergic beta-Antagonists; Atrial Fibrillation; Cardiac Surgical Procedures; Cardiovascular Agents; Diltiazem; Female; Humans; Male; Morpholines; Postoperative Complications; Urea | 2012 |
[Effect of landiolol hydrochloride for intraoperative tachycardia--multicenter questionnaire study].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Anesthesia, General; Female; Humans; Injections, Intravenous; Intraoperative Complications; Male; Middle Aged; Morpholines; Retrospective Studies; Surveys and Questionnaires; Tachycardia; Time Factors; Treatment Outcome; Urea | 2012 |
Determination of landiolol, an ultra-short-acting β₁-receptor antagonist, in human plasma by liquid chromatography-tandem mass spectrometry.
Topics: Adrenergic beta-Antagonists; Chromatography, High Pressure Liquid; Humans; Limit of Detection; Morpholines; Receptors, Adrenergic, beta-1; Reproducibility of Results; Tandem Mass Spectrometry; Urea | 2012 |
Low-dose β-blocker in combination with milrinone safely improves cardiac function and eliminates pulsus alternans in patients with acute decompensated heart failure.
Topics: Acute Disease; Adrenergic beta-Antagonists; Adult; Aged; Arrhythmias, Cardiac; Cardiotonic Agents; Chi-Square Distribution; Drug Therapy, Combination; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Japan; Male; Middle Aged; Milrinone; Morpholines; Prospective Studies; Pulmonary Wedge Pressure; Recovery of Function; Stroke Volume; Time Factors; Treatment Outcome; Urea; Ventricular Dysfunction, Left; Ventricular Function, Left | 2012 |
The effect of combined treatment with Impella(®) and landiolol in a swine model of acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Animals; Combined Modality Therapy; Disease Models, Animal; Heart; Heart-Assist Devices; Male; Morpholines; Myocardial Infarction; Myocardial Reperfusion; Myocardial Reperfusion Injury; Swine; Treatment Outcome; Urea | 2012 |
Very-low-dose continuous drip infusion of landiolol hydrochloride for postoperative atrial tachyarrhythmia in patients with poor left ventricular function.
Topics: Aged; Anti-Arrhythmia Agents; Coronary Artery Bypass; Female; Heart Diseases; Heart Rate; Heart Valve Prosthesis Implantation; Humans; Infusions, Intravenous; Intra-Aortic Balloon Pumping; Male; Middle Aged; Mitral Valve Annuloplasty; Morpholines; Stroke Volume; Tachycardia, Supraventricular; Treatment Outcome; Urea; Ventricular Function, Left | 2012 |
Long-term and spatial memory effects of selective β1-antagonists after transient focal ischaemia in rats.
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Cerebral Infarction; Ischemic Attack, Transient; Male; Maze Learning; Memory; Morpholines; Neuroprotective Agents; Propanolamines; Rats; Rats, Sprague-Dawley; Urea | 2012 |
Neuroprotective effects of selective β-1 adrenoceptor antagonists, landiolol and esmolol, on transient forebrain ischemia in rats; a dose-response study.
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Ischemic Attack, Transient; Male; Morpholines; Neuroprotective Agents; Propanolamines; Prosencephalon; Rats; Rats, Sprague-Dawley; Urea | 2012 |
Efficacy of landiolol hydrochloride for atrial fibrillation after open heart surgery.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Blood Pressure; Cardiac Surgical Procedures; Female; Heart Rate; Humans; Male; Middle Aged; Morpholines; Retrospective Studies; Treatment Outcome; Urea | 2013 |
Combination of β-blocker and milrinone for acute heart failure.
Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Cardiotonic Agents; Female; Heart Failure; Hemodynamics; Humans; Male; Milrinone; Morpholines; Urea; Ventricular Dysfunction, Left; Ventricular Function, Left | 2012 |
Antinociceptive effects of intrathecal landiolol injection in a rat formalin pain model.
Topics: Analgesics; Animals; Disease Models, Animal; Formaldehyde; Injections, Spinal; Male; Morpholines; Pain; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; RNA, Messenger; Urea | 2012 |
Acute hemodynamic effects of landiolol, an ultra-short-acting beta-blocker, in patients with acute coronary syndrome: preliminary study.
Topics: Acute Coronary Syndrome; Adrenergic beta-Antagonists; Blood Pressure; Female; Heart Rate; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Morpholines; Urea; Ventricular Function, Left | 2012 |
Influence of hemodynamic variations on the pharmacokinetics of landiolol in patients undergoing cardiovascular surgery.
Topics: Aged; Anti-Arrhythmia Agents; Anticoagulants; Cardiac Surgical Procedures; Female; Hemodynamics; Heparin; Humans; Liver; Male; Middle Aged; Morpholines; Regional Blood Flow; Urea | 2012 |
Landiolol for junctional ectopic tachycardia refractory to amiodarone after pediatric cardiac surgery.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiac Surgical Procedures; Constriction, Pathologic; Heart Septal Defects, Ventricular; Humans; Infant; Male; Morpholines; Pulmonary Artery; Tachycardia, Ectopic Junctional; Urea | 2013 |
Postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting or cardiac valve surgery: intraoperative use of landiolol.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Coronary Artery Bypass; Heart Valve Prosthesis Implantation; Humans; Intraoperative Care; Middle Aged; Morpholines; Postoperative Complications; Retrospective Studies; Urea | 2013 |
Landiolol hydrochloride infusion for treatment of junctional ectopic tachycardia in post-operative paediatric patients with congenital heart defect.
Topics: Anti-Arrhythmia Agents; Cardiopulmonary Bypass; Heart Defects, Congenital; Humans; Infant; Infusions, Intravenous; Male; Morpholines; Postoperative Care; Retrospective Studies; Tachycardia, Ectopic Junctional; Treatment Outcome; Urea | 2013 |
Acute rate control in atrial fibrillation with left ventricular dysfunction.
Topics: Adrenergic beta-1 Receptor Antagonists; Anti-Arrhythmia Agents; Atrial Flutter; Digoxin; Female; Heart Rate; Humans; Male; Morpholines; Tachycardia; Urea; Ventricular Dysfunction, Left | 2013 |
Effects of landiolol hydrochloride on intractable tachyarrhythmia after pediatric cardiac surgery.
Topics: Adrenergic beta-Antagonists; Cardiac Surgical Procedures; Child; Child, Preschool; Female; Heart Defects, Congenital; Heart Rate; Humans; Infant; Infant, Newborn; Male; Morpholines; Postoperative Complications; Retrospective Studies; Tachycardia; Urea | 2013 |
Does intravenous landiolol, a β1-adrenergic blocker, affect stroke volume variation?
Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Aged; Blood Pressure; Bradycardia; Carbon Dioxide; Cardiac Output; Female; Heart Rate; Humans; Male; Middle Aged; Morpholines; Prospective Studies; Stroke Volume; Urea; Vascular Resistance | 2013 |
Landiolol hydrochloride for early postoperative tachycardia after transthoracic esophagectomy.
Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Aged; Aged, 80 and over; Esophageal Neoplasms; Esophagectomy; Female; Humans; Male; Middle Aged; Morpholines; Postoperative Complications; Tachycardia; Treatment Outcome; Urea | 2014 |
Atrial fibrillation after esophageal cancer surgery: an analysis of 207 consecutive patients.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Atrial Fibrillation; Colon; Esophageal Neoplasms; Esophagectomy; Esophagoplasty; Female; Heart Rate; Humans; Ileum; Logistic Models; Male; Middle Aged; Morpholines; Postoperative Complications; Risk Factors; Tachycardia; Urea | 2014 |
Dose-dependent effect of landiolol, a new ultra-short-acting β(1)-blocker, on supraventricular tachyarrhythmias in postoperative patients.
Topics: Adrenergic beta-Antagonists; Aged; Arrhythmias, Cardiac; Dose-Response Relationship, Drug; Female; History, 17th Century; Humans; Male; Morpholines; Postoperative Period; Prospective Studies; Receptors, Adrenergic, beta-1; Urea | 2013 |
Novel use of the ultra-short-acting intravenous β1-selective blocker landiolol for supraventricular tachyarrhythmias in patients with congestive heart failure.
Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Atrial Fibrillation; Blood Pressure; Drug Administration Schedule; Female; Heart Failure; Heart Rate; Humans; Infusions, Intravenous; Japan; Male; Middle Aged; Morpholines; Tachycardia, Supraventricular; Time Factors; Treatment Outcome; Urea | 2014 |
Clinical experience with landiolol hydrochloride in conservative management of blunt aortic injury.
Topics: Adrenergic beta-Antagonists; Adult; Aorta; Aortography; Humans; Male; Morpholines; Tomography, X-Ray Computed; Urea; Wounds, Nonpenetrating | 2013 |
Preoperative morphological analysis by transesophageal echocardiography and predictive value of plasma landiolol concentration during systolic anterior motion mitral valve repair : a report of three cases.
Topics: Adrenergic beta-Antagonists; Aged; Anti-Arrhythmia Agents; Echocardiography, Three-Dimensional; Echocardiography, Transesophageal; Female; Humans; Male; Middle Aged; Mitral Valve; Mitral Valve Insufficiency; Morpholines; Preoperative Care; Prognosis; Urea | 2014 |
[Anesthetic and perioperative management of a patient with uncontrolled thyrotoxicosis undergoing coronary artery bypass grafting surgery].
Topics: Adrenergic beta-Antagonists; Anesthesia, Inhalation; Angina, Unstable; Coronary Artery Bypass; Female; Humans; Intraoperative Care; Middle Aged; Morpholines; Thyrotoxicosis; Urea | 2013 |
A low-dose β1-blocker effectively and safely slows the heart rate in patients with acute decompensated heart failure and rapid atrial fibrillation.
Topics: Acute Disease; Adrenergic beta-Antagonists; Aged; Atrial Fibrillation; Female; Heart Failure; Heart Rate; Humans; Male; Morpholines; Urea | 2014 |
Cost minimization analysis of beta-blocker at the time of CT imaging for suspected of coronary heart disease in Japan.
Topics: Adrenergic beta-Antagonists; Coronary Angiography; Coronary Disease; Decision Trees; Health Expenditures; Humans; Japan; Morpholines; Sensitivity and Specificity; Tachycardia; Tomography, X-Ray Computed; Urea | 2014 |
Structural analysis of an impurity of the drug landiolol.
Topics: Drug Contamination; Magnetic Resonance Spectroscopy; Mass Spectrometry; Molecular Structure; Morpholines; Urea | 2014 |
Effect of landiolol hydrochloride after off-pump coronary artery bypass.
Topics: Adrenergic beta-Antagonists; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Coronary Artery Bypass, Off-Pump; Drug Administration Schedule; Female; Heart Rate; Humans; Incidence; Infusions, Intravenous; Intensive Care Units; Japan; Length of Stay; Male; Middle Aged; Morpholines; Time Factors; Treatment Outcome; Urea | 2013 |
Significant reversal of cardiac upregulated endothelin-1 system in a rat model of sepsis by landiolol hydrochloride.
Topics: Animals; Blood Gas Analysis; Disease Models, Animal; Endothelin-1; Hemodynamics; Interleukin-6; Male; Morpholines; Myocardium; Rats, Wistar; Receptors, Endothelin; Sepsis; Tumor Necrosis Factor-alpha; Ultrasonography; Up-Regulation; Urea | 2014 |
Optimal dose of landiolol for preventing abrupt changes in both cardiac output and middle cerebral artery flow velocity after electroconvulsive therapy.
Topics: Adrenergic beta-Antagonists; Blood Flow Velocity; Blood Pressure; Cardiac Output; Cerebrovascular Circulation; Dose-Response Relationship, Drug; Electrocardiography; Electroconvulsive Therapy; Electroencephalography; Female; Heart Rate; Humans; Male; Middle Aged; Morpholines; Oximetry; Ultrasonography, Doppler, Transcranial; Urea | 2014 |
Potential amelioration of upregulated renal HIF-1alpha-endothelin-1 system by landiolol hydrochloride in a rat model of endotoxemia.
Topics: Animals; Biomarkers; Blood Gas Analysis; Blood Pressure; Disease Models, Animal; Endothelin-1; Endotoxemia; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Inflammation Mediators; Kidney; Lipopolysaccharides; Male; Morpholines; Rats, Wistar; RNA, Messenger; Up-Regulation; Urea | 2014 |
The role of β-blockers in cardiac perioperative management.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Atrial Fibrillation; Coronary Artery Bypass; Drug Administration Schedule; Humans; Infusions, Intravenous; Injections, Intravenous; Morpholines; Risk Factors; Treatment Outcome; Urea | 2014 |
Target-controlled infusion and population pharmacokinetics of landiolol hydrochloride in gynecologic patients.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Asian People; Blood Pressure; Drug Delivery Systems; Female; Gynecologic Surgical Procedures; Heart Rate; Humans; Infusions, Intravenous; Middle Aged; Models, Statistical; Morpholines; Perioperative Care; Urea | 2015 |
[Successful anesthetic management of a patient with giant pheochromocytoma using high-dose landiolol hydrochloride].
Topics: Adrenal Gland Neoplasms; Analgesia, Epidural; Anesthesia, General; Arrhythmias, Cardiac; Catecholamines; Contraindications; Heart Rate; Humans; Hypertension; Infusions, Intravenous; Injections, Intravenous; Intraoperative Complications; Male; Middle Aged; Morpholines; Phentolamine; Pheochromocytoma; Urea | 2014 |
[Awake intubation with landiolol and dexmedetomidine in a patient with anxiety neurosis].
Topics: Anesthesia, General; Anxiety; Anxiety Disorders; Dexmedetomidine; Emergencies; Female; Hemostasis, Surgical; Humans; Hypnotics and Sedatives; Intubation, Intratracheal; Laryngoscopes; Middle Aged; Morpholines; Postoperative Hemorrhage; Thyroidectomy; Urea; Wakefulness | 2014 |
Preventive effect of intraoperative landiolol administration on atrial fibrillation after off-pump coronary artery bypass grafting.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Coronary Artery Bypass; Coronary Artery Bypass, Off-Pump; Drug Monitoring; Female; Heart Rate; Humans; Incidence; Intraoperative Care; Japan; Male; Morpholines; Postoperative Complications; Retrospective Studies; Time Factors; Treatment Outcome; Urea | 2014 |
Effect of landiolol hydrochloride on tachyarrhythmia after esophagectomy.
Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Calcium Channel Blockers; Digitalis Glycosides; Drug Therapy, Combination; Esophagectomy; Female; Heart Rate; Humans; Japan; Male; Middle Aged; Morpholines; Retrospective Studies; Tachycardia; Treatment Outcome; Urea | 2014 |
Design of a prospective observational survey on landiolol in atrial fibrillation/atrial flutter patients with chronic heart failure - AF-CHF landiolol survey.
Topics: Adrenergic beta-Antagonists; Adverse Drug Reaction Reporting Systems; Aged; Atrial Fibrillation; Atrial Flutter; Female; Heart Failure; Humans; Japan; Male; Morpholines; Prospective Studies; Research Design; Urea | 2015 |
Efficacy of landiolol for the treatment of junctional ectopic tachycardia resulting from sepsis.
Topics: Anti-Arrhythmia Agents; Child, Preschool; Female; Humans; Morpholines; Sepsis; Tachycardia, Ectopic Junctional; Treatment Outcome; Urea | 2016 |
[Successful sedation with landiolol and dexmedetomidine during spinal anesthesia in a patient with active dementia].
Topics: Aged, 80 and over; Anesthesia, Spinal; Dementia; Dexmedetomidine; Femoral Fractures; Humans; Hypnotics and Sedatives; Male; Morpholines; Urea | 2015 |
Evaluation of near infrared spectroscopy for detecting the β blocker-induced decrease in cerebral oxygenation during hemodilution in a swine model.
Topics: Adrenergic beta-Antagonists; Animals; Brain; Hemodilution; Hemodynamics; Models, Animal; Monitoring, Physiologic; Morpholines; Oximetry; Oxygen; Propanolamines; Spectroscopy, Near-Infrared; Sus scrofa; Urea | 2015 |
Thyroid Storm with Heart Failure Treated with a Short-acting Beta-adrenoreceptor Blocker, Landiolol Hydrochloride.
Topics: Adrenergic beta-Antagonists; Aged; Atrial Fibrillation; Electric Countershock; Female; Heart Failure; Heart Rate; Humans; Infusions, Intravenous; Morpholines; Tachycardia; Thyroid Crisis; Thyroidectomy; Treatment Outcome; Urea | 2015 |
Successful Treatment of Refractory Electrical Storm With Landiolol After More Than 100 Electrical Defibrillations.
Topics: Adrenergic beta-Antagonists; Aged, 80 and over; Coronary Angiography; Electric Countershock; Electrocardiography; Humans; Male; Morpholines; Myocardial Infarction; Tachycardia, Ventricular; Treatment Outcome; Urea | 2015 |
An Experience of Landiolol Use for an Advanced Heart Failure Patient With Severe Hypotension.
Topics: Adrenergic beta-1 Receptor Antagonists; Atrial Fibrillation; Biological Availability; Cardiomyopathy, Dilated; Electrocardiography; Heart Failure; Humans; Hypotension; Intra-Aortic Balloon Pumping; Male; Mitral Valve Insufficiency; Morpholines; Severity of Illness Index; Treatment Outcome; Urea; Ventricular Dysfunction, Left; Young Adult | 2015 |
Effects of landiolol on refractory tachyarrhythmia after total cavopulmonary connection: a retrospective, observational, cohort study.
Topics: Blood Pressure; Child; Child, Preschool; Cohort Studies; Female; Fontan Procedure; Heart Rate; Humans; Male; Morpholines; Postoperative Period; Pulmonary Artery; Retrospective Studies; Tachycardia; Tachycardia, Supraventricular; Urea | 2016 |
Efficacy and Safety of Landiolol Compared to Amiodarone for the Management of Postoperative Atrial Fibrillation in Intensive Care Patients.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Critical Care; Female; Humans; Male; Middle Aged; Morpholines; Postoperative Complications; Retrospective Studies; Urea | 2016 |
[Relationship between the Landiolol Dose and Urinary Catecholamine Metabolites in the Perioperative Management of Patients Undergoing Pheochromocytoma Resection].
Topics: Adrenal Gland Neoplasms; Adrenergic beta-Antagonists; Adult; Catecholamines; Female; Humans; Male; Middle Aged; Morpholines; Pheochromocytoma; Retrospective Studies; Urea | 2015 |
Impact of a β-blocker and/or acute hemodilution on cerebral oxygenation during apneic hypoxia.
Topics: Adrenergic beta-Antagonists; Animals; Apnea; Brain; Hemodilution; Hypoxia; Morpholines; Oxygen; Spectroscopy, Near-Infrared; Swine; Urea | 2016 |
Radiation-Dose-Lowering Effects of Landiolol Hydrochloride in Coronary Angiography Using Computed Tomography (DELIGHT) - A Prospective Multicenter Study.
Topics: Blood Pressure; Coronary Angiography; Heart Rate; Humans; Morpholines; Myocardial Ischemia; Prospective Studies; Radiation Dosage; Tomography, X-Ray Computed; Urea | 2016 |
Lower Radiation Exposure Needs Lower Heart Rate.
Topics: Coronary Angiography; Heart Rate; Humans; Morpholines; Radiation Dosage; Radiation Exposure; Tomography, X-Ray Computed; Urea | 2016 |
Alteration of fatal 1:1 conducted atrial flutter to less conducted ratio by landiolol infusion.
Topics: Aged, 80 and over; Atrial Fibrillation; Atrial Flutter; Electrocardiography; Humans; Male; Morpholines; Urea; Ventricular Dysfunction, Left | 2016 |
Switching therapy from intravenous beta blocker to bisoprolol transdermal patch for atrial fibrillation tachycardia.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Bisoprolol; Blood Pressure; Critical Care; Female; Heart Rate; Humans; Injections, Intravenous; Male; Middle Aged; Morpholines; Retrospective Studies; Transdermal Patch; Urea | 2016 |
Beneficial effect of early infusion of landiolol, a very short-acting beta-1 adrenergic receptor blocker, on reperfusion status in acute myocardial infarction.
Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Morpholines; Myocardial Infarction; Myocardial Reperfusion; Percutaneous Coronary Intervention; Prospective Studies; Treatment Outcome; Urea | 2016 |
Comparison of the β-Adrenergic Receptor Antagonists Landiolol and Esmolol: Receptor Selectivity, Partial Agonism, and Pharmacochaperoning Actions.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-2 Receptor Antagonists; Blood Pressure; Cyclic AMP; Drug Partial Agonism; Heart Rate; HEK293 Cells; Humans; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Morpholines; Phosphorylation; Propanolamines; Propranolol; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Urea | 2016 |
[Anesthetic Management of a Patient who Developed Intraoperative Paroxysmal Supraventricular Tachycardia with Pulseless Electric Activity].
Topics: Adrenergic beta-Antagonists; Aged; Anesthetics; Anti-Arrhythmia Agents; Electrocardiography; Female; Heart Arrest; Humans; Intraoperative Complications; Morpholines; Postoperative Period; Preoperative Care; Tachycardia, Supraventricular; Urea | 2016 |
Landiolol hydrochloride ameliorates acute lung injury in a rat model of early sepsis through the suppression of elevated levels of pulmonary endothelin-1.
Topics: Acute Lung Injury; Adrenergic beta-Antagonists; Animals; Down-Regulation; Endothelin-1; Lung; Male; Morpholines; Rats, Wistar; RNA, Messenger; Sepsis; Tumor Necrosis Factor-alpha; Urea | 2016 |
Successful Management of Fulminant Guillain-Barré Syndrome and Its Complications.
Topics: Adrenergic beta-Antagonists; Child, Preschool; Female; Glucocorticoids; Guillain-Barre Syndrome; Humans; Immunization, Passive; Magnetic Resonance Imaging; Morpholines; Plasmapheresis; Respiration, Artificial; Urea | 2018 |
Use of a Short-Acting β1 Blocker During Endotoxemia May Reduce Cerebral Tissue Oxygenation if Hemodynamics are Depressed by a Decrease in Heart Rate.
Topics: Adrenergic beta-Antagonists; Animals; Blood Gas Analysis; Blood Pressure; Cardiac Output; Endotoxemia; Heart Rate; Hemodynamics; Lipopolysaccharides; Morpholines; Stroke Volume; Swine; Urea | 2017 |
Dobutamine, a β1 Adrenoceptor Agonist, Increases Cerebral Oxygenation During Acute Anemia and Apneic Hypoxia.
Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-Antagonists; Animals; Apnea; Cerebrum; Disease Models, Animal; Dobutamine; Hypoxia; Morpholines; Oxygen Consumption; Spectroscopy, Near-Infrared; Swine; Urea | 2017 |
Switching Therapy from Intravenous Landiolol to Transdermal Bisoprolol in a Patient with Thyroid Storm Complicated by Decompensated Heart Failure and Gastrointestinal Dysfunction.
Topics: Administration, Cutaneous; Administration, Intravenous; Adrenergic beta-Antagonists; Adult; Atrial Fibrillation; Bisoprolol; Female; Gastrointestinal Diseases; Heart Failure; Humans; Morpholines; Thyroid Crisis; Treatment Outcome; Urea | 2017 |
Landiolol is effective for the treatment of tachycardia-induced cardiogenic shock in patients during septic shock therapy.
Topics: Aged; Anti-Arrhythmia Agents; Diagnosis, Differential; Electrocardiography; Female; Humans; Morpholines; Shock, Cardiogenic; Shock, Septic; Tachycardia, Supraventricular; Urea | 2017 |
Landiolol dramatically improved Takotsubo cardiomyopathy in an older patient.
Topics: Aged; Humans; Morpholines; Takotsubo Cardiomyopathy; Treatment Outcome; Urea | 2017 |
Advantage of landiolol over esmolol? We doubt it!
Topics: Adrenergic beta-Antagonists; Heart Rate; Humans; Morpholines; Propanolamines; Urea | 2018 |
[Postoperative Atrial Fibrillation in Patients who Underwent Thoracic Aortic Surgery].
Topics: Aged; Aged, 80 and over; Aorta, Thoracic; Atrial Fibrillation; Female; Humans; Male; Middle Aged; Morpholines; Postoperative Complications; Risk Factors; Thoracic Surgical Procedures; Urea | 2018 |
Landiolol hydrochloride to successfully treat refractory ventricular arrhythmia during weaning from cardiopulmonary bypass.
Topics: Aged; Anti-Arrhythmia Agents; Cardiopulmonary Bypass; Electric Countershock; Female; Humans; Male; Morpholines; Tachycardia, Ventricular; Treatment Outcome; Urea; Ventricular Fibrillation | 2018 |
Sex-Mediated Response to the Beta-Blocker Landiolol in Sepsis: An Experimental, Randomized Study.
Topics: Adrenergic beta-Antagonists; Animals; Female; Heart; Magnetic Resonance Imaging; Male; Morpholines; Rats; Rats, Wistar; Sepsis; Sex Factors; Stroke Volume; Treatment Outcome; Urea; Ventricular Function, Left | 2018 |
Landiolol Hydrochloride Rapidly Controls Junctional Ectopic Tachycardia After Pediatric Heart Surgery.
Topics: Adrenergic beta-Antagonists; Blood Pressure; Child, Preschool; Female; Heart Defects, Congenital; Heart Rate; Humans; Infant; Infant, Newborn; Intensive Care Units, Pediatric; Male; Morpholines; Postoperative Complications; Retrospective Studies; Tachycardia, Ectopic Junctional; Time Factors; Urea | 2018 |
Cardioselective ultra-short-acting β-blockers for patients with Takotsubo syndrome?
Topics: Adrenergic beta-1 Receptor Antagonists; Humans; Morpholines; Takotsubo Cardiomyopathy; Urea | 2018 |
We need more useful surrogate markers for the efficacy of beta-blockers for the treatment of Takotsubo cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Female; Humans; Infusions, Intravenous; Morpholines; Natriuretic Peptide, Brain; Prognosis; Recovery of Function; Takotsubo Cardiomyopathy; Treatment Outcome; Troponin I; Urea | 2018 |
Landiolol hydrochloride for preventing postoperative atrial fibrillation.
Topics: Atrial Fibrillation; Humans; Incidence; Morpholines; Risk Factors; Urea | 2018 |
Low-Dose Landiolol Reduces Heart Rate and Cardiac Oxygen Consumption Without Compromising Initial Hemodynamic Resuscitation in a Canine Model of Endotoxin Shock.
Topics: Animals; Cardiac Output; Dogs; Female; Heart Rate; Hemodynamics; Male; Morpholines; Oxygen Consumption; Resuscitation; Shock, Septic; Urea | 2019 |
[Hyperthyroidism Diagnosed from Refractory Tachycardia and Hypotension during Surgery: A Case Report].
Topics: Blood Pressure; Female; Heart Rate; Humans; Hyperthyroidism; Hypotension; Injections, Intravenous; Middle Aged; Morpholines; Propranolol; Tachycardia; Urea | 2016 |
Effects of Landiolol in Lipopolysaccharide-Induced Acute Kidney Injury in Rats and In Vitro.
Topics: Acute Kidney Injury; Animals; Cytokines; Lipopolysaccharides; Male; Morpholines; Rats; Rats, Wistar; Urea | 2019 |
Differential Effectiveness of Landiolol Between Atrial Fibrillation and Atrial Flutter/Atrial Tachycardia Patients With Left Ventricular Dysfunction.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Humans; Male; Middle Aged; Morpholines; Retrospective Studies; Tachycardia; Urea; Ventricular Dysfunction, Left | 2019 |
Effective Dose of Landiolol, an Ultra-Short-Acting β-Blocker, to Decrease Heart Rate During On-Pump, Beating Coronary Artery Bypass Grafting.
Topics: Adrenergic beta-Antagonists; Aged; Cohort Studies; Coronary Artery Bypass; Dose-Response Relationship, Drug; Female; Heart Rate; Humans; Infusions, Intravenous; Male; Middle Aged; Morpholines; Treatment Outcome; Urea | 2019 |
What Determines the Response to Landiolol?
Topics: Atrial Fibrillation; Atrial Flutter; Humans; Morpholines; Tachycardia; Urea; Ventricular Dysfunction, Left | 2019 |
What Determines the Response to Landiolol? - Reply.
Topics: Atrial Fibrillation; Atrial Flutter; Humans; Morpholines; Tachycardia; Urea; Ventricular Dysfunction, Left | 2019 |
A prospective observational survey on landiolol in atrial fibrillation/atrial flutter patients with chronic heart failure - AF-CHF landiolol survey.
Topics: Adrenergic beta-Antagonists; Aged; Atrial Fibrillation; Atrial Flutter; Chronic Disease; Female; Heart Failure; Heart Rate; Humans; Japan; Male; Middle Aged; Morpholines; Prospective Studies; Surveys and Questionnaires; Treatment Outcome; Urea | 2019 |
Use of low-dose β
Topics: Adrenergic beta-Antagonists; Adult; Aged; Cardiac Surgical Procedures; Catecholamines; Female; Heart Rate; Hemodynamics; Humans; Japan; Male; Middle Aged; Morpholines; Postoperative Complications; Retrospective Studies; Tachycardia, Sinus; Tertiary Care Centers; Urea; Young Adult | 2019 |
Successful treatment of neonatal idiopathic ventricular tachycardia with landiolol hydrochloride.
Topics: Anti-Arrhythmia Agents; Female; Humans; Infant, Newborn; Morpholines; Remission Induction; Tachycardia, Ventricular; Urea | 2019 |
A Penny Saved Should Be a Penny Earned.
Topics: Atrial Fibrillation; Cost-Benefit Analysis; Germany; Humans; Morpholines; Urea | 2020 |
Successful Combination of Landiolol and Levosimendan in Patients with Decompensated Heart Failure.
Topics: Adrenergic beta-Antagonists; Aged; Cardiotonic Agents; Drug Therapy, Combination; Female; Heart Failure; Humans; Male; Morpholines; Simendan; Tachycardia; Urea | 2020 |
β-blockade in sepsis: regulation of persisting sepsis-related tachycardia.
Topics: Humans; Morpholines; Sepsis; Tachycardia; Urea | 2020 |
Comparison of Landiolol and Digoxin as an Intravenous Drug for Controlling the Heart Rate in Patients with Atrial Fibrillation and Severely Depressed Left Ventricular Function.
Topics: Administration, Intravenous; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Blood Pressure; Digoxin; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Morpholines; Retrospective Studies; Severity of Illness Index; Stroke Volume; Tachycardia; Treatment Outcome; Urea; Ventricular Dysfunction, Left | 2020 |
Rate control in atrial fibrillation using Landiolol is safe in critically ill Covid-19 patients.
Topics: Aged; Atrial Fibrillation; COVID-19 Drug Treatment; Critical Illness; Female; Heart Rate; Hospitalization; Humans; Intensive Care Units; Male; Morpholines; Patient Safety; Prospective Studies; Treatment Outcome; Urea | 2021 |
Suppression of amiodarone-induced torsade de pointes by landiolol in a patient with atrial fibrillation-mediated cardiomyopathy.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiomyopathies; Electrocardiography; Female; Humans; Morpholines; Torsades de Pointes; Urea | 2021 |
Safety and Efficacy of Landiolol Hydrochloride in Children with Tachyarrhythmia of Various Etiologies.
Topics: Atrial Fibrillation; Child; Humans; Infant; Morpholines; Retrospective Studies; Tachycardia; Urea | 2021 |
Effect of Landiolol Hydrochloride on Hemodynamics in a Histamine-Induced Shock Model.
Topics: Adrenergic beta-Antagonists; Animals; Dogs; Heart Rate; Hemodynamics; Histamine; Humans; Morpholines; Urea | 2021 |
Anaphylactic shock in a patient with severe aortic stenosis treated with adrenaline and landiolol for circulatory management: A case report.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Aged, 80 and over; Anaphylaxis; Aortic Valve Stenosis; Echocardiography; Epinephrine; Female; Humans; Morpholines; Postoperative Complications; Rocuronium; Spinal Fractures; Sugammadex; Urea | 2021 |
Clinical usefulness of left ventricular outflow tract velocity time integral for heart failure with reduced ejection fraction with rapid atrial fibrillation during landiolol treatment.
Topics: Atrial Fibrillation; Heart Failure; Hospital Mortality; Humans; Morpholines; Prognosis; Prospective Studies; Stroke Volume; Urea; Ventricular Function, Left | 2022 |
Effect of landiolol in patients with tachyarrhythmias and acute decompensated heart failure (ADHF): a case series.
Topics: Heart Failure; Humans; Morpholines; Tachycardia; Urea | 2022 |
The application of landiolol in the cardiovascular and intensive care
Topics: Atrial Fibrillation; Critical Care; Heart Rate; Humans; Morpholines; Myocardial Infarction; Urea | 2022 |
Control of Heart Rate in Infant and Child Tachyarrhythmia With Reduced Cardiac Function Using Landiolol (HEARTFUL) - Results of a Prospective, Multicenter, Uncontrolled Clinical Study.
Topics: Adrenergic beta-Antagonists; Atrial Fibrillation; Child; Heart Rate; Humans; Hypotension; Infant; Prospective Studies; Tachycardia; Urea | 2022 |
Heart rate control with landiolol hydrochloride in infants with ventricular dysfunction and pulmonary hypertension.
Topics: Child; Critical Illness; Female; Heart Rate; Humans; Hypertension, Pulmonary; Infant; Infant, Newborn; Infant, Premature; Male; Retrospective Studies; Tachycardia; Tachycardia, Sinus; Urea; Ventricular Dysfunction | 2023 |
[Effect of Landiolol for Atrial Fibrillation after Open Heart Surgery].
Topics: Adrenergic beta-Antagonists; Atrial Fibrillation; Cardiac Surgical Procedures; Female; Humans; Male; Morpholines; Postoperative Complications; Risk Factors; Urea | 2023 |